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Bloodstream infections (BSIs) are a critical concern in modern medicine due to 
their continued prevalence in modern hospitals, along with high costs and attributable 
mortality, particularly among those who are immunocompromised. The current gold 
standard for detection and characterization of causative pathogens involves cell culture, 
which can take 24-48 hours to complete, increasing time to adequate treatment and thus 
mortality. The rise of antimicrobial resistance in hospital acquired infections has reduced 
the effectiveness of broad spectrum antimicrobial treatments, resulting in a clear need for 
a rapid, sensitive technique for characterization of resistance markers in microbial 
pathogens without cell culture. Here we present the development of a microfluidic platform 
for polymerase chain reaction (PCR) mediated amplification of microbial gene targets in a 
continuous flow system for potential coupling with sample preparation systems to reduce 
time to diagnosis from days to within two hours. This culminated in a thermoelectric cooler 
mediated fluidic thermocycler with a recirculating assay region for real-time hybridization 
measurements to minimize assay time. 
 vii 
We subsequently demonstrated development of a low-cost optical system for 
localized surface plasmon resonance imaging using a digital micromirror device and tuned 
nanoprism monolayers for DNA hybridization with a spectral resolution of 2nm. This 
LSPR imaging system was integrated in-flow into the microfluidic thermocycler, enabling 
detection of input E. coli DNA samples at a minimum concentration of 5fg/µL. We further 
demonstrated multiplex detection of target markers, indicating potential for assaying target 
panels for characterization of pathogens. Overall, the studies in this dissertation 
demonstrate a microfluidic PCR system with built-in sensitive LSPR detection of DNA 
hybridization. It should serve as a starting point for exploration of and expansion with 
fluidic sample preparation with a focus on rapid characterization of pathogens. 
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CHAPTER 1: 
Introduction 
1.1 MEDICAL DIAGNOSTICS AND THE MODERN AGE 
  The field of medicine has seen something of a renaissance over the last century 
with the introductions of biochemistry, molecular biology and modern pathology. As 
recently as the 1920s, respected scientists and physicians ascribed to Galen’s theory of the 
four humours, first originating in ancient Greece by Hippocrates and perpetuated through 
Roman medicine all the way up to the late 19th century when increased focus on 
microbiology and the physical underpinnings of disease finally began to put the theory to 
rest, largely as a result of the work of individuals such as Louis Pasteur[1] and Robert 
Koch[2], and aided by rapid development in microscopy technology led by Ernst Abbe and 
Carl Zeiss[3]. While support for such concepts had eroded over centuries of prior scientific 
advancement, this period of scrutiny and classification of pathogens and medical 
techniques, coupled with other factors such as the initial discovery of deoxyribonucleic 
acid (DNA) and the details of heredity, laid the groundwork for modern medicine. 
 Not to be outdone by the 19th century, the modern age has seen an explosion in 
medical technology, matching advances in science across the board. In medical imaging 
and diagnostics alone, numerous modalities have been proposed, developed and then 
improved again for application to increasingly varied problems. X-ray systems pioneered 
by Wilhelm Roentgen were adapted to tomography, then computed tomography (CT)[4], 
then variant analysis techniques such as dual energy. Magnetic Resonance Imaging (MRI), 
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initially developed as recently as 1971[5], has already expanded to a massive array of 
specialized systems and techniques, from fMRI to MR angiography. While these 
modalities, along with ultrasound, photoacoustic imaging and PET offer a wide range for 
macro-level and tissue measurements[6], and electron microscopy and NMR provide a 
wealth of information at the molecular level[7], in microbiology optical microscopy and 
imaging are still king, particularly in applications dealing with studies of microbial 
pathogens. Conventional light microscopy, fluorescence, confocal, super-resolution 
techniques (PALM, STORM, atomic force microscopy)[8], dark-field, hyperspectral and 
other spectroscopic methods all provide valuable information for a subset of applications. 
Faster cameras, digital interfaces, segmentation and other algorithms have all contributed 
to the potential for more complex imaging systems and diagnostics.  
Optical imaging systems also have a strong cross-over potential with 
miniaturization, another modern trend in both consumer electronics and medical 
devices[9]. The dream of a small-scale diagnostic tool with a wide range of potential 
applications, much like the tricorder of Star Trek fame, has long been an attractive direction 
of research. The advent of molecular assays along with miniaturization of imaging 
technology and electrochemical detection techniques have brought this dream closer to 
fruition than ever before, but there is still a long way to go before it is possible to simply 
wave an instrument over a patient and instantly know anything that is wrong with them. 
To strive ever closer to this goal, assays and detection schemes must be designed and 
coupled with simple, rapid sensing in mind. 
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1.2 MICROFLUIDICS AND POINT-OF-CARE 
 Miniaturization of fabrication and molecular assay technology has led to the field 
of microfluidics, or systems designed to process samples in very small volumes, generally 
ranging from microliter down to picoliter scale[10]. Taking diagnostics down to such scales 
brings with it a number of highly attractive properties: high surface area to volume ratio is 
advantageous for a number of applications, such as sensing on arrays with improved 
detection efficiency[11]. Short cross-sectional distances allow for manipulation of samples 
with precise application of electric or magnetic forces, enabling Lab-on-a-chip applications 
designed to perform complicated tasks or assays on a single microchip. Of course, these 
advantages come with the drawback of very small sample volumes, which can make 
detection of low concentration analytes difficult and increases the challenges of scaling up 
throughput to match clinical samples in such cases[12]. 
 Originally born out of MEMS (micro electromechanical systems) in the 1980s, such 
improvements in micromachining and patterning allowed for the fabrication of the level of 
small-scale chips necessary for microfluidics[13]. Since then, the field has spread to 
encompass a wide range of materials and disciplines, ranging from silicon-based MEMS 
to PDMS soft lithography[14] to paper-based assays that have been gaining ground in 
recent years[15]. The potential for highly sensitive bioassays using only a small sample has 
significant draw, and there have been several high profile successes related to 
microfluidics. Table 1.1 attempts to list some of the more notable microfluidic success 
stories, perhaps the most well-known of which are the blood glucose meter and the home 
pregnancy test. 
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Table 1.1. Selected commercial microfluidic applications. 
System Operating Principles Year 
Handheld Glucometer Paper test strip, enzymatic assay 1981[16] 
Home Pregnancy Test Paper test strip, wicking + hCG 
sandwich immunoassay 
1980s (1988 
for monoclonal 
antibodies)[17] 
IonTorrent (Roche) Next-gen Sequencing, semi-conductor 
based pyrosequencing 
2012[18] 
LabChip (Perkin Elmer) Capillary Gel Electrophoresis, 
Spectrophotometry 
2000[19] 
Ink-jet Printer Head MEMS, Thermal Inkjet Printing 1985[20] 
 
 An important observation from such successes that is often overlooked, is that 
microfluidics has historically been at its most valuable when focused on point-of-care 
diagnostics. While complex lab-on-chip sensors can be of tremendous research value and 
demonstrate concepts that will certainly be useful in the years to come, many require 
careful external control and manipulation, with a dizzying array of parts and pumps to 
enable a complex assay on a microchip. In contrast to this vision of so-called ‘chip-in-a-
lab’, microfluidics as a field is uniquely situated for point-of-care systems[21, 22], with 
simple to control assays that can quickly process clinical samples and provide feedback in 
a physician’s office, or at worst, hospital laboratory with minimal fuss, enabling early 
detection or rapid quantification of biomarkers[23]. 
 In such a setting, the principle challenges are in developing low-cost robust fluidic 
assays with sensitive detection schemes and scaling up to systems capable of high 
throughput for analysis of clinical samples where necessary. Notably, applications such as 
simple molecular biomarker assays and blood tests[24], separation of molecules or even 
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cells[25], as in flow-assisted cell sorting and dielectric separation of circulating tumor cells 
(CTCs)[26], and identification of pathogens through antibiotic susceptibility testing[27], 
holography[28] or genetic characterization are ideal avenues of exploration for point-of-
care focused microfluidic devices.  
1.3 NANOTECHNOLOGY AND THE INTERFACE WITH MICROFLUIDICS 
 Nanotechnology, broadly defined as the study and/or manipulation of matter with 
at least one dimension below 100 nanometers[29], has enormous and far reaching 
implications in medicine and diagnostics. While the term nanotechnology covers a vast 
array of technologies, applications in the biomedical field alone are staggering. Carbon 
nanotubes are being studied for targeted drug delivery[30], man-made metamaterials use 
nano-scale patterning to create bulk properties that flaunt established physics for 
advantageous attributes in applications such as hyperlenses for super-resolution imaging 
in both optical[31] (net negative refractive index) and ultrasound systems[32] (net negative 
density), nano-electronics allow for biosensing of minute electrochemical shifts during 
binding events[33, 34], and nanoparticles of all types have tremendous applications for 
both diagnostics – as the basis for highly sensitive assays or contrast agents for traditional 
imaging techniques[35] – and therapeutics – for thermal ablation of tumors[36] and drug 
delivery[37], among others. 
 Due to the similarity in scale, there is tremendous overlap between microfluidics 
and nanotechnology. Nano-fluidics and nano-electronics are the most obvious examples, 
the former is a mainstay of many classical microfluidic systems, and the latter allows for 
increasing levels of miniaturization in detection. Nanoparticles themselves also have 
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significant application in microfluidic devices, largely in terms of detection – plasmonic 
detection of noble metal nanoparticles has seen increasing use, as it can be label-free, 
highly sensitive, and couples well with flow cell design[38-40]. Paper-based microfluidics 
have also made extensive use of plasmonic nanoparticles, particularly the large shift in 
extinction peak observed when trapping gold nanoparticles in close proximity to each other 
in the presence of a target analyte[41] – an approach popular for some variants of the home 
pregnancy test[42]. In addition, magnetic nanoparticles, such as superparamagnetic iron 
oxide, have been used for magnetophoretic manipulation of sample flows and droplets to 
rapidly achieve complex mixing and washing steps for micro-assays[43, 44]. On the other 
side, microfluidic syntheses for a number of nanoparticle regimes have been demonstrated 
to improve monodispersity and reproducibility[45, 46], and more accurate characterization 
has been achieved through microfluidic monitoring of dynamic light scattering and zeta 
potential[47]. 
 Of particular interest in this work are the applications of plasmonics and noble 
metal nanoparticles to biomarker sensing in microfluidic applications. Surface plasmon 
resonance (SPR)[48], localized surface plasmon resonance (LSPR)[49] and surface 
enhanced Raman scattering (SERS)[50] have all been successfully demonstrated for label-
free sensing in microfluidic systems. In fact, the first commercial device incorporating SPR 
detection, from Biacore, fit squarely into this paradigm – utilizing a shallow flow cell with 
a thin gold layer coating the substrate for plasmonic sensing[51]. LSPR arrays have 
enormous potential as a sensing modality in microfluidics due to its applicability to a wide 
range of assay designs and potential targets. LSPR arrays formed from gold and silver 
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nanoparticles of a variety of shapes, as well as sputter coating mediated nanosphere 
lithography[52] and gold nanoholes[53] have been demonstrated for micro-assays. 
1.4 OUTLINE OF SPECIFIC AIMS 
 The aims of this dissertation will guide development of a microfluidic system for 
the rapid characterization of microbial pathogens through real-time detection of PCR 
amplified genetic markers of antimicrobial resistances. The studies performed here will 
focus on the sequential design, prototyping, validation, and testing of the various 
components required for the functioning of such a device integrating microfluidic assays 
and nanoparticle-based detection techniques for exceptional sensitivity and multiplexing. 
Further, a prototype of a completed system will be verified and characterized for detection 
of amplified Escherichia coli DNA from bacterial lysate for both single target and 
multiplex analysis. To that end, the three aims of this dissertation are as follows: 
1) First, we will construct and test the core microfluidic structure of the device. 
This includes developing a continuous flow Polymerase Chain Reaction (PCR) 
thermocycler and all attendant components with potential for addition of real-time 
detection of DNA amplicons. We will demonstrate a design paradigm culminating in a 
recirculating channel on a Peltier thermocycler for rapid continuous-flow PCR 
amplification. A recirculating channel will allow for more rapid detection of target markers 
than a traditional continuous flow system, as the amplicons will tend to accumulate in the 
looped channel and allow bulk PCR while maintaining fluidic flow rates. We will further 
demonstrate separate regulation of in-channel flow using pumping methods with no parts 
external to the channel, and characterize the resulting systems for optimal pumping 
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conditions to achieve desired flow profiles. These experiments will then lead to verification 
of a recirculating PCR thermocycling chip for amplification of target markers from E. coli 
DNA. 
2) Secondly, we will develop and test an optical Localized Surface Plasmon 
Resonance Imaging (LSPRi) based detection scheme for use with a functional zone located 
inside the recirculating PCR channel. Silver nanoprisms have proven to be an ideal 
nanostructure for LSPR applications due to their high anisotropy and sharp edges[54], so 
silver nanoprism synthesis will be optimized for stability and functionalization for use in 
an LSPR array. An optical system will be constructed and verified in which white light is 
diffracted to separate out the visible spectrum and then directed onto a digital micromirror 
device (DMD), which will be used to isolate specific frequencies onto a fiber optic to pass 
them through the LSPRi detection zone and onto a CCD camera. The optical system will 
be characterized through imaging of nanoparticle monolayers under solvents with varying 
dielectric constants to demonstrate sensitivity. 
3)  Finally, we will finalize the device by combining the systems developed for aim 
1 and aim 2 and then validate it using bacterial lysate. This will consist of integrating the 
LSPRi detection scheme into the microfluidic channel by immobilizing and functionalizing 
nanoprisms inside the recirculating PCR channel and wiring LED and camera control to 
function concurrently with fluidic power and control systems. . Real-time detection of 
target accumulation will be made by measuring the shift in the absorption of the 
hybridization region by integrating the difference between images at each wavelength and 
their corresponding reference images prior to analysis. The system will be verified for PCR 
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amplification and tested for limit of detection using a concentration series of input DNA 
from E. coli. Single target and multiplex PCR will be performed and matched to 
conventional PCR output to demonstrate functionality and potential for further 
development. 
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CHAPTER 2: 
Background 
2.1 MOTIVATION: BLOODSTREAM INFECTIONS  
Bloodstream infections (BSIs, also called septicemia or bacteremia in the case of 
bacterial origins) are infections that have spread to the blood and are a critical concern in 
modern medicine[55]. BSIs can result from both bacterial and fungal infections, most 
notably those of the urinary tract, lungs, kidneys and abdomen[56, 57]. When left 
untreated, they can spread into the bloodstream, allowing for easy access of pathogens and 
toxins to other systems throughout the body, leading to significant risk of systemic 
infections that can be lethal[58]. Bloodstream infections presented at hospitals are grouped 
into three classifications: community acquired (unrelated to healthcare, presented with a 
BSI on admission), hospital acquired, and healthcare related (presented with BSI on 
admission, acquired through outpatient services)[59]. Approximately 2% of hospital 
admissions are related to cases of community acquired BSIs, most commonly related to 
respiratory tract infections[60]. 
 In addition to patients who present with BSIs, hospital acquired, or nosocomial, 
BSIs remain a persistent problem even in the most advanced of clinics – most notably 
secondary infections related to main-line catheterization[61, 62]. In 2002 alone, an 
estimated 250,000 healthcare-associated infections occurred in the US, with over 30,000 
estimated deaths[63]. While the causes and prognosis of BSIs in various forms has been 
well studied[64] and many procedural changes have been proposed/adopted to limit 
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them[61, 65, 66], BSIs continue to be a problem. Approximately 5% of all patients in the 
US get an infection during their hospitalizations[67], and the risks of such infections 
increase with duration of hospital stay, catheterization[68], low nurse-to-patient ratio[69] 
and a number of other factors[70]. The likelihood of nosocomial infection jumps 
dramatically for patients undergoing critical care, such as ICU patients[71, 72]. It also 
exceeds 15% among the immunocompromised[73], who are also at increased risk for 
polymicrobial infections[74] which carry an increased mortality[75], making BSIs a 
considerable risk for patients undergoing chemotherapy, a notable cause of neutropenia. In 
addition, hospital acquired and healthcare related BSIs are significantly more likely to be 
caused by drug resistant pathogens than community acquired ones, making treatment more 
difficult[57, 76]. 
Though generally treatable, these infections carry a high mortality rate, ranging 
from 16 - 40% in ICU patients[77, 78]. Time to adequate treatment has a significant impact 
on survival rate[79], but antibacterial resistance is linked to an increase in time to adequate 
treatment due to the likelihood that the initial round of antimicrobials is ineffective [80, 
81]. To combat this, treatment of BSIs generally consists of broad-spectrum 
antimicrobials[82], however this can contribute to further antimicrobial resistances[83, 84], 
as well as increased cost. Rising rates of antibacterial resistance as well as increasing 
numbers of BSIs caused by fungi and gram positive bacteria have only worsened this 
effect[85, 86]. Even for those who survive BSIs, the length of hospital stay is prolonged 
by 4.5 - 32 days[77, 78, 87] and incur significant cost, up to $39,000 per episode[78, 87, 
88] leading to an estimated annual cost of $60 – 460 million in the US alone[89]. As a 
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result, timely characterization of pathogens to facilitate effective intervention is critical to 
decreasing the burden of nosocomial infections. 
2.2 THE RISE OF SUPERBUGS 
 As discussed above, hospital acquired bloodstream infections are more likely to be 
caused by drug resistant pathogens, as well as gram positive bacteria or fungi that require 
different classes of antimicrobials and are thus generally increase time to adequate 
treatment[57, 76]. These are due to both the rising rates of antimicrobial resistance[90, 91], 
so-called superbugs, and hospital conditions that lead to more uncommon infections. Close 
proximity of patients[91], incomplete sanitization, and bodily fluids transferred from one 
room to another on lab wear can all contribute to bringing pathogens together[92, 93]. 
Bacteria often undergo conjugation, allowing plasmids containing genes that confer 
antimicrobial resistance to be passed between populations in a polymicrobial setting[94, 
95]. In addition, incomplete treatment, due to improper dosage or duration[96], can result 
in surviving mutant populations with resistances that then spread through the hospital 
setting. While effective for reducing time to adequate treatment in BSIs with unknown 
pathogens, overtreatment with broad spectrum antimicrobials can also confer resistance 
through mutant populations[97, 98]. 
 All of these factors contribute to the increasing rates of antimicrobial resistance, 
which is now considered by the CDC and medical community at large to be a global 
threat[99-102], resulting in at least two million drug resistant infections and upwards of 
23,000 deaths in the United States alone[103, 104]. Notably, strains of some of the more 
common serious gram-negative pathogens, such as Enterobacteriaceae and Acinetobacter, 
 13 
have developed resistances to virtually all known antimicrobials that would be used to treat 
them, becoming pan-resistant[105-107]. Rates of antifungal resistance have recently begun 
rising in common fungal infections, such as Candida[108, 109], indicating that they are not 
far behind on this trend. 
 The CDC has made a number of recommendations to stem the tide of antimicrobial 
resistances, most notably including more stringent preventative measure and sterilization, 
more controlled usage of antibiotics, and careful tracking of drug resistant strains and 
sharing of said data between hospitals.[103] While these recommendations will likely aid 
in reducing the rate at which drug resistance spreads, they can also make treatment of acute, 
unknown infections such as BSIs more difficult, as broad spectrum treatment without 
knowledge of efficacy or dosing would be inadvisable. 
2.3 APPROACHES TO RESISTANCE CHARACTERIZATION 
 As patient outcome in the case of bloodstream infection depends heavily on time to 
adequate treatment, there has been significant motion in recent years towards faster 
detection, however none have been able to supplant clinically standard procedures. The 
standard procedure for clinical lab work in the case of a suspected infection is to take an 
immediate blood sample for lab analysis[110]. Once in the lab, blood samples are treated 
with a blood lysis buffer, generally consisting of saponin, for aggregation and lysis of red 
blood cells, propylene glycol and sodium polyanetholesulfonate[111]. Following this, 
samples are often divided for different culture techniques, such as agar media culture and 
blood culture and then spread on the appropriate plate and left overnight[112]. Cell culture 
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can often take upwards of 24 hours[110], and is the limiting step in classical detection of 
microbial pathogens. 
 Following cell culture, resulting pathogens must be identified and characterized for 
resistances. One of the most common and direct techniques for detection of antimicrobial 
resistances, antimicrobial sensitivity testing (AST)[113, 114], probes the capability of 
commonly used antimicrobials to lyse bacteria to determine both resistance and the 
minimum inhibitory concentration (MIC), defined as the lowest concentration at which the 
pathogen does not grow. Common methods for AST include disk diffusion and 
microdilution testing. Disk Diffusion AST consists of a bacterial culture plate with a 
number of small disks carrying antimicrobial agents at known concentrations[115, 116]. 
Bacterial cells are smeared on the plate and allowed to grow. Antimicrobials they are 
susceptible to create a growth exclusion zone around the disk, the diameter of which 
correlates to susceptibility[117]. The downsides to this technique are that it is imprecise 
and very slow – matching cell culture times[113]. Microdilution testing is more precise, 
dilution series of an array of antimicrobial agents are loaded into a microwell plate[118]. 
Bacterial samples are loaded into each and observed for growth. This allows for precise 
margins on MIC determination, as well as testing for a wide range of antimicrobials. For 
these reasons, microdilution testing is currently the gold standard for antimicrobial 
susceptibility testing, but it is still slow – generally requiring overnight culture to 
complete[113]. 
 Attempts have been made to speed up AST, forgoing or at the very least reducing 
the need for cell culture timeframes. In recent years, a number of alternative techniques 
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have been proposed, including MALDI-TOF[119], microfluidic AST[27], heated agarose 
inoculated with drugs for testing to trap and optically measure individual cell growth[120], 
fluorescent signal measurement[121], among others. While some of these techniques have 
resulted in highly sensitive, rapid detection, they still require large numbers of pathogen 
cells for functionality, preventing use directly from clinical samples. 
Besides AST, and often run concurrently, is PCR (polymerase chain reaction) 
amplification of pathogen DNA targeting a panel of genes that can allow for the 
identification of species, and markers of antimicrobial resistances[122-124]. Since all 
biological activities depend on genetic code, markers exist and have been identified for a 
wide range of known bacterial drug resistances[125-127]. Multiplex PCR can be used to 
amplify a panel of such markers of resistance and/or pathogen species, and characterize the 
pathogens[128-130]. PCR is also highly sensitive, as will be discussed further below, 
creating strong potential for assays performed without prior cell culture. This technique 
does still have disadvantages – only known resistance markers can be assayed, and no 
dosing information is provided beyond prior experience with similarly characterized 
pathogens. It does still, however, provide an attractive, rapid, method for early 
characterization. 
2.4 POLYMERASE CHAIN REACTION 
2.4.1 Principles of Operation 
Polymerase Chain Reaction (PCR) has become a cornerstone of modern molecular 
biology with a wide range of applications[131], from detecting bacterial resistance markers 
to crime labs[132, 133] to paternity tests[134, 135] to cloning for genomic sequencing[136, 
 16 
137]. First developed in 1983 by Kary Mullis[138], PCR amplifies DNA by repetitively 
copying a target sequence to achieve a theoretical two-fold increase in copy number per 
cycle[139, 140]. With this geometric increase, a very small quantity of target DNA 
sequences can be amplified to copy numbers in the millions, limited only by starting 
concentrations of primers, free nucleotides and reaction kinetics[141]. 
 
Figure 2.1. Schematic representation of polymerase chain reaction sequence of steps. In step 1, 
high heat denatures dsDNA molecules. In step 2, primers anneal to single stranded DNA at target 
sequences. In step 3, DNA polymerase incorporates free nucleotides to extend primers and 
complete dsDNA sequences. Image credited to the Wikimedia Foundation. 
 
The technique relies on DNA Polymerase, an enzyme responsible for extending 
double-stranded DNA (dsDNA) from a starting primer bound to a template strand. 
Temperature cycling is utilized to achieve three sequential temperature steps.[138, 139] 1) 
Denaturation – at 94-96C, DNA denatures into complementary single stranded molecules 
(ssDNA). DNA denaturation temperatures (melting temperature, Tm) vary significantly 
with the length of the sequence[142], GC content[143] and secondary structure[144], but 
95C is sufficient for nearly all potential targets to melt. 2) Annealing – typically between 
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58-65C, the annealing temperature is defined by the melting temperatures of the primer 
sequences used[145, 146]. During this step, the temperature is held just below the Tm of 
the primers, allowing them to bind to the template DNA, the target sequences in the 
denatured DNA. Two primers are used per target gene, one for the 3’ end, one for the 5’, 
allowing for extension on both complementary halves of the denatured DNA. 3) Extension 
– typically at 72C, the ideal functional temperature for the Taq polymerase[147], the most 
commonly used polymerase in PCR. During this step, the polymerase enzyme binds to the 
primer/template complex and extends it using free floating nucleotides, creating two new 
dsDNA strands from the single strand present before the cycle. Other reaction components 
include free nucleotides (dNTPs), which are used to create new DNA strands, and 
magnesium ions (Mg2+), which are required for activation of DNA polymerase[148, 149]. 
PCR is a robust system, but there are a number of common failure modes. For most, 
precise temperature control is the key to prevention. Overheating during the denaturing 
step can lead to damage to the polymerase – even at standard denaturing temperatures, the 
Taq polymerase has a half-life of approximately 40 minutes[147, 150], and this decreases 
at higher temperatures. Cooling too far during the annealing step can lead to primer-dimer: 
at low temperatures the ordinarily unstable bond can form between the primers, leading to 
extension of small (~50bp) sequences[145, 151, 152]. Once this occurs, the primers can no 
longer be used to amplify target sequences. Notably, this effect can occur even in 
storage[153], which is why many modern polymerase enzymes have been modified to be 
so-called ‘hot-start’, meaning that they have been bound to an inhibitor, which is cleaved 
at ~90C, preventing primer-dimer extension in storage[154, 155]. Finally, some materials 
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can bind or damage DNA sequences[156], inhibit polymerase activity[157], or bind 
magnesium ions[158, 159], preventing polymerase activation (notably including EDTA, a 
metals chelator and common component in DNA storage media[160]). Some of these can 
be prevented using additives, common PCR adjuvants include bovine serum albumin[161, 
162], which forms monolayers on material surfaces and improves biocompatibility, and 
TWEEN-20[163, 164], which neutralizes some detergents, such as sodium dodecyl sulfate 
(SDS), and prevents some protein interactions. 
While PCR could theoretically turn even one copy of a target gene into a near 
infinite amount, there are both lower and upper bounds on its function. At the low end, a 
minimum number of copies the target are necessary for PCR to take place, though the 
precise number has been placed anywhere from 10-300 copies[165, 166]. This translates 
to theoretical minimum quantities of DNA from cellular sources – for a single allele target 
with only one copy per cell, 100 copies correlates to ~400pg for human cells (~4pg/cell) 
or 1.7pg for E. coli (~0.017pg/cell). At the upper end, very high initial DNA quantities can 
inhibit PCR – massive quantities of non-target DNA reduce access to the target sequences. 
This effect, combined with the half-life of polymerase and the limited quantity of dNTPs 
in a reaction lead to practical maximum amplification – the plateau region of the growth 
curve. 
2.4.2 Thermocycling Methods 
 As precise temperature control during PCR steps is among the most important 
factors in ensuring successful amplification, conventional thermocycling systems are 
generally carefully engineered for thermal accuracy and stability over speed of cycling. 
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Over the years, commercially available thermocyclers have undergone a significant 
evolution, primarily focused on increasing cycling speed while maintaining precision – 
even slight decreases in the length of a cycle add up over the course of 40 cycles. The 
earliest thermocycling systems consist of heating blocks – large chunks of copper with 
holes drilled for vials or well plates[167]. The high thermal conductivity of copper (385 
W/mK[168]) results in a homogenous temperature even with a heating source far removed 
from the sample wells, and relatively slow changes in temperature that can be precisely 
measured with a thermocouple[169]. Typically, these systems use one-directional thermal 
control – only heating is supplied, and cooling is achieved by allowing the block to radiate 
off excess heat. The next advance from these involved addition of a heated pad to sit on 
top of sample vials to reduce temperature gradients[170]. 
 Modern PCR systems utilize a number of disparate approaches. The new common 
paradigm in commercial PCR utilizes air-heated systems[171, 172], in which samples are 
held in a small sealed air pocket which is heated while an internal fan keeps the air moving. 
While air has a much lower thermal conductivity (0.024W/mK), thermal homogeneity is 
maintained by the induced air flow, and the low density allows for fairly rapid heating. 
Cooling in these systems is much faster, as the seal is released to allow the air to mix with 
ambient until the temperature falls to the target point. This requires very careful 
automation, as the temperature falls rapidly, and failure to reseal the chamber can quickly 
lead to reduced temperatures and primer-dimer errors. 
 Smaller scale and microfluidic PCR systems often follow one of two designs: (1) 
reaction chambers, often fabricated from silicon, which are heated using an integrated 
 20 
thermal sensor and a classic heating block design[173-175], and (2) temperature zones, in 
which a flow path repeatedly passes over a set of three zones set to PCR step 
temperatures[176, 177]. This creates slight temperature gradients at the boundaries 
between regions, but as long as flow rates are held evenly throughout the system, successful 
amplification can be achieved. The largest concern in microfluidic thermocycling is the 
formation of bubbles[178, 179] – microbubbles formed either from incomplete wetting at 
channel walls or a liquid sample that hasn’t been degassed – expand rapidly under heating, 
wreaking havoc on carefully controlled flow rates and creating pressure spikes that can 
induce leaks and damage channels, and can also lead to nano-scale temperature gradients 
that interfere with precise thermocycling due to the aforementioned low thermal 
conductivity. 
 Regardless of thermocycling technique, precise control of temperature is critical to 
successful amplification, meaning that thermal sensing is a key part of any thermocycler. 
There are a number of precision thermal sensing systems – the most notable of which are 
thermocouples, thermistors, resistance thermal detectors (RTDs), material expansion 
sensors and infrared sensors. Classical analog thermometers use material expansion, 
historically of mercury, but more recently with colored water to avoid toxicity. While these 
can be made in digital forms, they have a slow response to change and are therefore 
uncommon in thermocyclers. Thermocouples are by far the most common thermal sensing 
element in modern use[180]: two different metals are joined, the difference in temperature 
gradient between the two results in electric current generation due to the Seebeck effect, or 
dV = -S(T)dT, where S(T) is a material dependent Seebeck constant. This same effect is 
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utilized in the opposite direction for Peltier-based thermoelectric heating elements. 
Thermocouples have a very wide range of operation, which has led to their use in 
commercial and industrial operations[181, 182]. 
 First observed by Michael Faraday, thermistors[183, 184] and RTDs[185] have 
very similar methods of operation – both rely on temperature driven changes in resistance 
to measure. While RTDs are technically a sub-class of thermistors, RTDs are almost 
exclusively constructed from resistive metals such as platinum[186], while the term 
thermistor is generally used to refer to semiconductor or metal-oxide film based sensors. 
Both have improved reproducibility and reduced drift compared to thermocouples, but 
have a smaller operating range – generally up to a maximum of ~600F[187]. While 
thermistors are more tunable to specific application, the usage of resistive metals in RTDs 
allows for a linear dependence on temperature, while most thermistors are exponential. 
2.5 MICRO-TOTAL ANALYSIS SYSTEMS 
2.5.1 Principles and History 
 Following the first development of microfluidic systems, commonly attributed to 
the gas chromatograph by Terry, et al,[188] as the first miniature analysis system on silicon, 
it actually took years before the field hit its stride and expanded into biosensing, during 
which time research focus was primarily on fluidic control systems. In 1990, the term 
micro-total-analysis system (µTAS) was coined by Manz, et al,[189] though at the time it 
was ‘miniaturized total chemical analysis systems’, as biosensing had not yet become a 
mainstay. Micro-total analysis systems (µTAS) refers to a branch of microfluidics, also 
referred to as lab-on-a-chip, focused on systems capable of taking input samples and 
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performing assays and detection on the same device[190, 191]. Typically, µTAS design 
consists of some sample processing system as well as sensors and assay control for the 
specific application and a built-in detection regime to analyze output[13, 192, 193]. While 
such sensors are not limited to medical devices, and indeed did not begin there, the ultimate 
goal for any clinically relevant µTAS system is to be able to take a raw clinical sample as 
input and achieve sensitive and specific output data on target analytes or biomarkers[194]. 
 Since their introduction, µTAS systems have seen a boom in applications in recent 
years, particularly in the late 1990s, as miniaturization techniques improved, leading to 
new control and fabrication paradigms, including the introduction of SU-8 photoresist 
mediated patterning[195, 196]. Micro-total analysis systems have been demonstrated for a 
stunning array of applications, from the initial µTAS for chromatography to biomarker 
analysis[197-199], to separations systems[44, 200, 201] and specific assays for 
applications such as antimicrobial susceptibility testing[27]. Detection schemes and assay 
design similarly run the gamut, though there are a number of commonalities throughout 
the field. Biocompatible materials such as polymethylmethacrylate (PMMA)[202, 203], 
polydimethylsiloxane (PDMS)[204, 205], polyetheretherketone (PEEK)[206, 207], silicon 
and glass are commonly used[208], as are photopolymers for precise formation of fluidic 
channel structures using photolithography[209], though there have been many successful 
systems based on other substrates, most notably paper, which has demonstrated popularity 
due to its significant potential for point-of-care assays[15, 210, 211]. Photolithography is 
also commonly used in conjunction with sputter coating to create patterned microelectrodes 
for both sensing and fluid flow systems[212]. Surface passivation systems, such as the 
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creation monolayers of biocompatible proteins such as bovine serum albumin (BSA) are 
commonplace in biosensing applications[213]. 
 Advances in clean room techniques, including plasma-bonding for PDMS-glass 
interfaces[214], microcontact printing for simple patterning of minute features and 
molecular layers[215], and three-dimensional construction of microchips[216, 217] have 
all led to improvements in miniaturization and potential for biosensing. The advent of 
nanotechnology, rising from the same miniaturization trends that spawned microfluidics, 
has proved to have a strong cross-over with µTAS, providing further improvements in 
sensitivity and new potential assays for development. 
 While microfluidics and µTAS have grown exponentially in popularity and 
complexity, this has come at a price: ever increasing complexity of fabrication and 
structural design increases both the cost of construction and the likelihood of device failure. 
Highly complex microchips can also prove difficult to clean, preventing re-usability. This 
combined with limited reliability leads to limited application for point-of-care diagnostics. 
Miniaturization can also be taken too far, leading to low throughput and the infamous 
problem of ‘scaling up’ a microfluidic system[218]. As a result of these issues, µTAS 
systems have gained a reputation as ‘chip-in-a-lab’, envisaging a small microchip that can 
perform amazing feats – so long as it is hovered over by a team of watchful scientists. In 
order to take µTAS out of the research lab and into clinical usage, it is necessary to design 
systems to accommodate clinical samples from the start, not as an afterthought. 
 
 
 24 
2.5.2 Fluidic Control Systems 
 Given the titular nature of ‘fluidics’ in microfluidics, control systems for fluid 
manipulation and flows are understandably a vital part of the field. One of the most central 
tenets of microfluidics is control of flow profiles – laminar and turbulent flow. While 
turbulent flow refers to the chaotic mixing and whorls often seen in fluid flows, laminar 
flow occurs when fluid forms parallel streams that characteristically do not mix. The 
crossover between the two forms of fluid flow were first demonstrated by Reynolds in 
1883[219] where he showed that turbulent and laminar flow could be visualized using dye 
in a pipe under different circumstances, and that over a length, turbulent flow actually 
became laminar. He further postulated the Reynolds number, 𝑅𝑒 =
𝜌𝑉𝐷𝐻
𝜇
, where ρ is the 
density of fluid, µ is the dynamic viscosity, V is the maximum velocity, and DH is the 
hydraulic diameter of the channel, 𝐷𝐻 =
4𝐴
𝑃
, where A is the cross-sectional area and P is 
the wetted perimeter. At low Reynolds numbers (<103, occurring when the channel has a 
large surface area-to-volume ratio, as in most microfluidics), laminar flow occurs, whereas 
turbulent flow occurs at higher Reynolds numbers[220]. As laminar flow is highly 
advantageous for a number of microfluidic applications[11, 221, 222], notably 
separations[223], maintaining a low Reynolds number is important. 
 Flow throughout microfluidic systems, especially continuous flow, is often 
maintained through external means. Fluid flow in microfluidics is generally seen as 
analogous to electrical current[224] – pressure is analogous to voltage, flow rate to current, 
and flow resistivity to resistance. Syringe pumps are heavily used to generate a constant 
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volumetric flow rate[12, 225], although these can result in large pressure spikes in highly 
resistive systems, leading to leakage and other problems. Alternatively, consistent pressure 
gradients can be applied either through pressure on a reservoir maintained through careful 
pressure sensing[224, 226], or by creating large height differentials between sample 
reservoirs to generate potential energy in the system[227]. In both of these cases, careful 
calibration and measurement of the resistance of fluidic structures to flow, usually 
measured in liquid ohms – or the linear ratio of pressure to flow rate, to extend the 
aforementioned analogy. 
 To achieve complex sample analysis schemes, internal control of fluidic structures 
is also necessary – valves, internal pumping, micromixers and the like[203, 228]. 
Pneumatic microvalves are a mainstay of PDMS based devices[229]: flow channels 
crossing over very thin boundaries with sample channels are used to obstruct those flows 
when the valve is closed, pneumatic flow is lessened to remove the obstruction when open. 
For internal pumping, a number of strategies have seen use. Electroosmotic pumping is 
among the most popular[224, 230], relying on the use of a microelectrode to create a 
voltage differential in the Debye layer across a permeable channel to create net flow. 
Electrokinetic[231] and electrothermal[232] systems use similar properties, though all 
three result in very low flow rates (<5µL/m). For faster flow profiles, peristaltic pumping 
can be used in soft materials such as PDMS – a series of three pressure points are applied 
in series lengthwise in a channel to force flow[233]. Acoustic wave pumping using 
piezoelectric actuators has also been demonstrated[234], along with valveless piezoelectric 
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pumping, in which a buzzer is actuated between a pair of flow rectifiers to create net flow 
in one direction[235, 236]. 
2.6 DNA DETECTION STRATEGIES 
 In order to identify DNA sequences, notably after PCR amplification, it is necessary 
to detect them in some way, and, if possible, quantify. The most classic regime for DNA 
detection is fluorescence – fluorescent dyes that intercalate into DNA sequences and 
increase their signal, such as SybrGreen, EvaGreen and ethidium bromide can be used to 
detect the presence of DNA, and to a limited extent quantify based on signal strength[237-
239]. This is the basis of most real-time PCR (qPCR) systems, as it is a rapid and robust 
detection technique. The disadvantage of using such dyes is that they are non-specific – 
any DNA will bind and boost signal, preventing multiplex applications in real-time. Gel 
electrophoresis can separate DNA into bands by size[240], allowing for fluorescent 
imaging of multiple targets, but this cannot be done in a real-time analysis. Other systems 
have been proposed for non-targeted DNA measurements, but have not achieved 
saturation. 
 For multiplex, real-time applications, a further step is needed. DNA hybridization 
probes are short sequences of single stranded DNA, generally 20-25 base pairs in length, 
that bind with high affinity to a matching target sequence[241, 242]. This allows a target 
sequence to be detected. DNA probes are often bound to a fluorophore and a quencher in 
a hairpin configuration that keeps the fluorophore and quencher in close proximity[243] – 
on binding to target DNA, they are separated, allowing the fluorophore to emit light. While 
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this allows for specific targeting and multiplexing, it is limited by the number of distinct 
fluorophores that can be measured – generally only a few at a time using switching filters. 
 For massively multiplexed applications, the DNA hybridization array is ideal[244, 
245]. Probe sequences are immobilized on a substrate surfaces, often through avidin-biotin 
binding[246]. While this allows for spatial resolution of fluorescent signals for a large 
number of target sequences, the necessity for binding to a substrate eliminates the 
possibility for the hairpin configuration, meaning that separate labeling probes are needed 
to bind to DNA-probe complexes on the hybridization array to achieve fluorescent 
signal[247], thus complicating the process and requiring additional wash steps – one to 
remove non-adsorbed DNA samples, and a second to introduces the fluorescent probes. 
 A number of approaches have been developed in recent years for label-free 
hybridization – meaning that no separate ‘labeling’ marker is required for detection beyond 
previously immobilized probes. Barbaro, et al, demonstrated hybridization on a metal-
oxide-semiconductor field-effect transistor (MOS-FET) to detect electrical signal from 
binding events[248]. Perhaps of most interest due to potential application to a wide range 
of other assays, label-free plasmonic imaging of DNA hybridization has also been 
demonstrated for both surface plasmon resonance[249] and localized surface plasmon 
resonance systems[250]. 
2.7 NOBLE METAL PLASMONICS 
2.7.1 Surface Plasmon Resonance 
 A peculiar effect arising in metal thin films is the surface plasmon: a charge density 
wave at the interface between a metal thin film and a medium with a positive dielectric 
 28 
constant. P-polarized light reflected off of such an interface can, under certain 
circumstances, couple into these surface plasmons, reducing the energy of the reflected 
beam[48]. This effect only occurs under precise conditions, however. The metal film must 
have a negative dielectric constant, arising from a low refractive index and high extinction 
coefficient, which are only found in ‘noble’ metals – gold, silver and copper[251]. Even 
with such a thin film, the layer must be sandwiched between two dielectric media. Under 
these conditions, energy from light totally internally reflected of the surface will instead be 
partially transferred into surface plasmons, called plasmon coupling. This effect reaches a 
sharp peak at some angle past the critical angle for internal reflection, known as the surface 
plasmon resonant angle. This reflection angle depends on the wavelength of the light used, 
the thickness of the thin film, and the dielectric constants of the surrounding materials 
within reach of the evanescent field (~200nm)[252]. 
As the resonant angle depends on the local dielectric constant, it is possible to 
monitor changes such as those arising from increasing mass on the thin film surface[253]. 
Building from these basic principles, surface plasmon resonance was first utilized to 
interrogate monolayers on a substrate by Pockrand, et al in 1978[254], and subsequently 
for the first biosensing application by Liedberg, et al in 1983[255]. SPR biosensing utilizes 
total internal reflection off a noble metal thin film surface, typically ~5nm of gold, 
modulated to the resonant angle. Once tuned to the resonant angle, either angle or 
wavelength can be modulated to characterize plasmonic spectra[256]. The most common 
optical scheme for SPR was developed in 1971 by Kretschman, et al[257], utilizing a prism 
with a high refractive index to bend an incident light beam to an appropriate angle for total 
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internal reflection (Fig. 2.2). The light source can then be placed on a precise angular 
platform to allow for modulation of the reflection angle. This configuration has been 
reported to reach nanomolar detection for DNA hybridization applications[258], and the 
high level of sensitivity has led to the use of SPR in a wide array of sensing applications, 
including ELISA[259], allergen testing[260], and many others. 
 
 
Figure 2.2. Schematic representation of surface plasmon resonance (left). At or near the resonant 
angle, ϴr, energy from the reflected beam is transferred into surface plasmons along the boundary 
between the second dielectric and the metal film. (Right) Diagram of the Kretschmann 
configuration, in which a high refractive index prism is used to achieve bending of light for creating 
total internal reflection at angles sufficient for SPR to occur. Images credited to University of Liege 
HoloLab. 
 
 
Since then, many novel variants on SPR have been reported to achieve 
improvements on the sensitivity. For example, Homola, et al, reported SPR using 
elliptically polarized light[261], fluorescent spectroscopy coupled with SPR has seen 
attomolar detection[262], and SPR arrays have been built into optical fibers[263]. In 
addition to these variants, 2-dimensional SPR imaging has been utilized for visualizing 
arrays[264], allowing for multiplexed analysis, and some live cell imaging[265], though 
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this technique is less sensitive than its cousins, as it measures simple change in reflected 
beam signal rather than utilize spectroscopic data for higher sensitivity. 
2.7.2 Localized Surface Plasmon Resonance 
 Extending from Surface Plasmon Resonance biosensors, it was discovered that 
noble metal nanoparticles carried characteristic extinction peaks in the visible light 
spectrum due to a similar effect, and, much like plasmon coupling, the extinction peak 
depended in part on the local dielectric constant around the nanoparticle[49, 266]. This 
effect was termed localized surface plasmon resonance (LSPR). The precise location of 
this extinction peak is defined by Mie theory and Maxwell’s equations, resulting in the 
equation for the extinction spectrum of a metal sphere:  
𝐸(𝜆) =
24𝜋2𝑁𝑎3𝜀𝑜𝑢𝑡
3/2
𝜆ln⁡(10)
[
𝜀𝑖(𝜆)
(𝜀𝑟(𝜆) + ⁡𝜒𝜀𝑜𝑢𝑡)2 + 𝜀𝑖(𝜆)2
] 
Where⁡𝜀𝑟 and 𝜀𝑖 are real and imaginary portions of the metal dielectric constant, 𝜀𝑜𝑢𝑡 is the 
external dielectric constant, a is the size of the particle, and 𝜒 is a multiplicative factor that 
increases with aspect ratio.[266] This created the potential for biosensors based on direct 
transmission of light, eliminating the need for complex prism configurations for total 
internal reflection. Additionally, LSPR resulted in improved sensitivity over standard SPR, 
boasting picomolar detection.[267, 268] Mie theory also predicts significant red-shift in 
the extinction peak with close proximity between nanoparticles[269], which has led to 
further improvements on detection limit. 
 In addition to LSPR biosensors, the same phenomenon led to the development of 
Surface Enhanced Raman Scattering[270], which is believed to utilize excitation of 
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localized surface plasmons in nanoparticle surfaces to enhance Raman spectroscopy signal 
significantly. Both LSPR and SERS are commonly performed with carefully shaped 
nanoparticles such as rods or prisms, as such sharp edges lead to high anisotropy in the 
particles, and a large electromagnetic enhancement that increases shifts in the extinction 
peak[271]. 
 While colloidal LSPR has been demonstrated, most research in the field is focused 
on surface-bound nanoparticle arrays[272]. Nanosphere lithography is commonly used to 
create a monodisperse array of precise prism shapes[273] and substrate silanization can be 
used to adhere particles through other reactions[274], both resulting in regular arrays of 
nanoparticles for LSPR or SERS. Recently, nanohole arrays have become an increasing 
mainstay of LSPR applications, generally fabricated by electron beam treatment of a gold 
thin-film surface[275]. These have significantly improved optical properties and layer 
uniformity by design, at the cost of expensive instrumentation and highly challenging 
synthesis. 
2.7.3 Optical Measurements of LSPR 
 Since LSPR results in a shift in the extinction peak of nanoparticles under changes 
in the local dielectric constant rather than an angular shift such as that in SPR, direct 
measurements are possible. As a result, spectroscopy is the most common technique used 
for analyzing LSPR shift.[276] In addition to UV-Vis spectroscopy, Rayleigh scattering 
and Raman scattering spectroscopy both see use, the latter notably in SERS. Imaging 
applications have been demonstrated using 2D spectrophotometers in conjunction with 
microscope objectives to reduce background[271]. Darkfield microscopy, in which a 
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patch-stop ring is used in conjunction with a condenser to obtain phase-shift information, 
is also a mainstay in imaging of plasmonic particles[277], particularly in live cell 
applications[278]. Spectroscopy in some form is key to any LSPR application, as extinction 
shifts are small and difficult to spot with simple colorimetric sensors. Spectral 
measurements allow for significantly improved sensitivity without resorting to particle 
labeling. Hyperspectral measurements are strongly applicable to plasmonics, though this 
imaging technique is slow and provides limited spatial resolution[279]. 
 In most cases, LSPR is measured for particles immobilized on a substrate surface, 
generally functionalized with some probe in biosensor applications. Colloidal LSPR 
detection has also been demonstrated, but it is far less common[280]. Additionally, ultra-
high sensitivity LSPR has been demonstrated using a hybrid technique in which 
immobilized particles form complexes with colloidal particles with probes specific to the 
same target molecule. While this makes the sensor no longer label-free, nanoparticles in 
close proximity significantly red-shift their optical extinction spectra, leading to the 
possibility of colorimetric detection[281]. 
2.7.4 Nanoparticle Synthesis: Shapes and Sizes 
 As the field of nanotechnology has grown and gained increasing recognition and 
funding, the number of nanoparticle syntheses have been rising commensurately. 
Nanoparticles are now a mainstay of modern medicine, with applications in imaging and 
diagnostics, and treatment, including radiation therapy. Nanoparticles now come in an 
array of materials, including silver[282], gold[283], iron and iron oxide[284], 
polymers[285], silica[286] and many more. An astounding number of shapes have also 
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been demonstrated across the field – spheres[287], prisms[288], cubes[289], wires[290], 
rods[291], bipyramids[292], clusters[293], hybrid particles[294], and even specialized 
shapes. 
 While nanoparticles of various types have a wide range of applications, LSPR and 
SERS require noble metal nanoparticles – gold and silver – due to their unique dielectric 
properties, as discussed previously. In addition, electromagnetic enhancement resulting 
from sharp edges makes shapes such as prisms, plates, cubes, wires and rods ideal for such 
applications. As a result, significant effort has been expended in discovery of novel shapes 
and synthesis techniques for noble metal nanoparticles. While nanocubes and nanowires 
generally require precise reaction conditions in solvothermal reactions[289, 290, 295], 
nanoprisms and nanorods have been demonstrated in simpler synthesis regimes. Gold 
nanorods can be formed using reduction reactions by controlling the ratios of surfactant, 
generally cetrymethyltriammonium bromide (CTAB)[291, 296]. 
 Silver nanoprisms were first demonstrated by Jin, et al in 2001[288]. Starting from 
small silver nanospheres reduced from silver nitrate using sodium borohydride and sodium 
citrate, prisms were grown through photoinduction using light with peaks that stimulated 
the dipole and quadrupole moment of the desired prism size in the presence of a 
sequestering agent, bis(p-sulfonatophenyl)phenylphosphine (BSPP). They later expanded 
on this technique to allow for tuning of plasmonic peaks using laser light to excite the 
dipole moment[297].  
Following the initial demonstration of silver nanoprisms, many other approaches 
have been demonstrated – solvothermal approaches[298], seeded growth[299] and 
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peroxide etchants[300]. Nearly all such nanoprism synthesis techniques utilize a similar 
basic methodology – silver nanospheres are formed via sodium borohydride reduction, 
followed by growth of prisms in the presence of a surface stabilization agent – often 
polyvinylpirrolidine (PVP), sodium citrate, or other starch. This surface stabilization agent 
preferentially binds to the <100> facets of the nanoparticles, impeding addition of silver 
ions and creating directional growth on the <111> facets to form prism or bipyramidal 
shapes[301]. While surface stabilization is uniformly required to create the characteristic 
shape of nanoprisms, the actual technique for growth varies. Protocols have been reported 
utilizing a weaker secondary reducing agent, hydrogen peroxide as an etchant, or heat 
treatment to catalyze growth. 
2.8 RELEVANT LITERATURE SYNOPSIS 
 As discussed previously, the nature of often low pathogen concentrations present 
in bloodstream infections makes diagnosis directly from a clinical sample without cell 
culture difficult to accomplish - as reported by Seifert et al, many infections have bacterial 
concentrations below 15 CFU/mL[302]. As a result, rapid characterization of pathogens 
must be capable of detecting such low concentrations. As an amplification technique, 
polymerase chain reaction is an ideal pre-detection step, as it allows such small 
concentrations to be increased to detectable levels[166] and is already proven for resistance 
marker characterization in a wide range of pathogens[127, 303-305], meaning that the 
needed probe designs for detection are already extant. 
 Microfluidics provides significant advantage for PCR thermocycling, notably 
including more rapid temperature control, often below one minute per cycle[174, 306]. 
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While microfluidics and PCR have a long history together[307-310], very little focus has 
been put into non-fluorescent real-time multiplex amplification, which would have 
tremendous value for diagnosis of bloodstream infections. 
 While microfluidics and PCR have long been tied together, the same is true of 
plasmonic detection and DNA hybridization. The label-free nature and high sensitivity of 
localized surface plasmon resonance simplifies DNA hybridization pathways[49], and easy 
binding of DNA probes to noble metal nanoparticles through thiol-binding[311] has made 
DNA detection an attractive research option for the study of LSPR, using both surface 
hybridization[268, 312] and colloidal aggregation, first reported by Alivisatos et al as a 
hybrid nanoparticle synthesis technique[313, 314]. Despite such intense interest in the field 
as a whole, as reported by Sepulveda et al, there has been very little attention to multiplex 
detection outside of highly complex surface patterns such as nanorings[267]. Similarly, 
there has been surprisingly little usage of digital micromirror devices as an inexpensive 
alternative to spectroscopy in LSPR detection outside of waveguides[315, 316]. Clearly 
there is potential for expansion into low-cost, multiplex LSPR imaging coupled with PCR 
amplification, with an application waiting in pathogen characterization from bloodstream 
infections.  
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CHAPTER 3: 
Development of Rapid, Recirculating Microfluidic PCR 
3.1 ABSTRACT 
 Microfluidic systems, and micro-total analysis systems in particular, have become 
a mainstay of biosensing in recent years. Due to the potential for rapid assays, sensitive 
detection, and manipulation of fluid streams for accomplishing sample preparation, assay 
and detection tasks in series on a single device, microfluidics is ideal for applications such 
as detecting DNA markers correlating to antimicrobial resistance from low concentration 
pathogen samples. Polymerase Chain Reaction (PCR) is capable of robust, specific 
amplification of target genes from bulk DNA, even at very low quantities, leading to the 
possibility of detection from low pathogen concentrations. While microfluidic PCR has 
previously been demonstrated, the use of a recirculating thermocycling region with in-built 
detection zone has not. Such a system carries the advantage of true real-time detection to 
reduce assay time, in addition to having potential for multiplexing and amplification of 
very low concentrations due to bulk thermocycling. 
 In this chapter, we demonstrate the development of a microfluidic thermocycler 
utilizing thermoelectric heating with resistance temperature detector-mediated control for 
rapid cycling and precise control. We demonstrate between-step thermal cycling times 
below 10 seconds and a temperature precision within 0.5°C. Further, in-flow piezoelectric 
pumping is demonstrated to achieve potential flow rates of over 150µL/m in a recirculating 
channel. These elements are combined to demonstrate successful amplification of DNA 
with the potential for expansion using DNA hybridization array-based detection for 
multiplex analysis. 
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3.2 INTRODUCTION 
Due to the high cost and significant mortality incurred by hospital-acquired 
bloodstream infections[77, 78, 87], broad spectrum antibiotic treatments prior to receiving 
results from cell culture have become a standard treatment to presentation with BSI related 
symptoms, particularly in the immunocompromised[82]. While such treatment generally 
reduces the time to effective relief and thus mortality rate, it carries its own risks such as 
contributing to the increase in antibacterial resistance rates[83] – a critical concern in 
modern medicine. As a result, there is considerable interest in the development of 
techniques for faster characterization of pathogens while maintaining the sensitivity and 
precision of cell culture-dependent methods. 
One avenue for rapid analysis that has gained significant traction in recent years is 
microfluidics – small volume assays carry potential for a number of valuable advantages, 
including nano-scale physics for highly sensitive detection systems, ability for rapid and 
automated mixing and manipulation of small volumes, and integration of disparate systems 
without need for robotics[13, 190]. These advantages have led to the rise of so-called 
micro-total analysis systems (µTAS)[189], which aim to perform robust molecular assays 
directly from clinical samples, in both research applications and commercial systems for a 
wide range of target applications. Such µTAS systems are ideal for cases where low 
analysis time is necessary for a complex input sample, such as blood samples from 
suspected BSIs. 
While microfluidics carries these myriad strengths that can be applied to detection 
systems such as bacterial characterization, it also has a number of intrinsic downsides and 
design challenges to overcome. Microfluidics are often limited by small sample volumes, 
which reduces both throughput and the limit of detection[218] – while such assays are often 
highly sensitive, a low enough initial concentration of target analytes can result in none at 
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all being present in a tiny sample volume. Together, these effects lead to significant 
challenges in ‘scaling up’ a fluidic device to successfully process clinical samples. In 
addition, all microfluidic designs require careful consideration of flow profiles, surface 
wetting, microbubbles, materials selection and assay design. 
There are a number of potential avenues that have been explored for identification 
and characterization of bacterial samples, including genetic methods, holography[28], 
protein analysis[317], cytometry[318] and antimicrobial susceptibility testing[113]. While 
holography and cytometry have proven well-suited to microfluidic design, they are limited 
in the quantity of achievable information – species and a couple of molecular targets can 
be interrogated, but there is not enough potential for the level of detailed analysis needed 
for characterization of resistances to antibacterial drugs. Antimicrobial susceptibility 
testing is robust, but it is difficult to perform on small samples due to the limited quantity 
of pathogens present in blood specimens. Genetic analysis using polymerase chain reaction 
(PCR) to amplify target genes for subsequent measurement is a proven gold standard 
method that is regularly used following cell culture[128] and is also an attractive system 
for microfluidic µTAS design due to its relative simplicity and power. 
Fundamentally, PCR involves cycling through a series of precisely controlled 
temperatures that are designed to denature DNA, followed by annealing target sequences 
to short primer chains, and then extending those primers with a DNA polymerase enzyme. 
PCR is highly robust and sensitive, capable of amplifying samples down to very low 
quantities of a target gene[166], as well as being extendable to multiplex 
amplification[129]. Because it is non-destructive, it can be used in conjunction with any 
DNA detection method. A number of microfluidic PCR temperature cycling schemes have 
been demonstrated, generally utilizing either sample flow over a spatially-distributed series 
of temperature-controlled zones[176], or else holding the sample still in wells that are 
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subjected to local thermocycling[173], through either air- or substrate-based control. 
Detection methods are most commonly fluorescent qPCR or post-analysis fluorescent 
hybridization arrays, though other techniques have been demonstrated. The downside of 
these systems is that they either allow for real-time PCR, or a flow-through design that 
allows for higher throughput and analysis of clinical samples, but not both. For true rapid 
characterization of clinical scale pathogenic samples, both continuous flow and real-time 
detection are necessary. 
This chapter enumerates the development of a microfluidic thermocycler for 
continuous flow PCR amplification with potential for multiplexed real-time analysis. 
Beginning from air-based thermal zone designs, the design path evolved towards a 
continuous-flow, looped thermocycling system with potential for in-loop DNA 
hybridization-based multiplex detection for real-time measurements of PCR. In addition, 
this chapter demonstrates the development and characterization of an acoustic pumping 
regime for separated in-channel flow management of the looped thermocycling region. 
Finally, the chapter provides verification of successful PCR amplification using fluorescent 
detection of target DNA sequences. 
3.3 MATERIALS AND METHODS 
3.3.1 Synthesis of Microfluidic Chips 
The microfluidic chips used in this chapter were synthesized through a number of 
fabrication approaches. Most commonly, chips were fabricated using channel structures 
cut using a VL-200 CO2 laser (Universal Laser Systems, Scottsdale, AZ) from layers of 
dry-film adhesive (3M) (commonly called “transfer tape”), of- 50 or 100µm thickness 
bonded to polymethylmethacrylate (PMMA) or glass substrates. PMMA substrates were 
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cut to desired shapes and inlets/outlets using the same VL-200 laser. For channel structures 
with taller form profiles, shim materials of desired thicknesses, ranging from 50-400µm, 
(Artus, Englewood, NJ) were cut using a VL-200 laser and then bonded between layers of 
dry-film adhesive. PCR chips were constructed with a bottom layer of 36-gauge aluminium 
to maximize thermal conductivity. 
3.3.2 Microelectrode Patterning 
Microelectrodes were prepared using a photolithographic process. First, a negative mask 
of the desired microelectrode pattern was cut into a 5nm layer of chromium flash plater 
with ~0.2nm gold on a glass substrate using a Promaster Atlex SI exciplex laser (ATL 
Lasertechnik, Carlsbad, CA). A second gold blank was spin-coated in darkness with 
negative photoresist and then illuminated through the cut mask for 30 seconds with 
collimated UV light. The second blank was then immersed in aqua regia (80%v/v 
hydrochloric acid 30%, 20%v/v nitric acid 70%) for approximately 2 min, until the soft, 
unexposed photoresist and the gold layer beneath it were etched away. Finally it was 
immersed in concentrated sulfuric acid at 80°C until the underlying chromium layer and 
all remaining photoresist had dissolved away. The resultant patterned electrode on the 
second blank was then washed repeatedly with deionized water to remove any remaining 
acid. 
3.3.3 Thermocycling Control 
Heating for thermocycling was provided using a VT-127-1.0-1.3-7.1 30mmx30mm Peltier 
device (TE Technology, Traverse City, MI). Power was supplied using a 24V, 4A power 
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supply (BioTec NG 60-5). Temperature control was managed using a resistance thermal 
detector (RTD, 615-1123-ND 1kΩ, DigiKey, Thief River Falls, MN) connected to an 
Arduino Uno microcontroller running a custom PID control program. The circuit diagram 
and PCR thermocycling control code may be found in the appendix. 
3.3.4 Piezoelectric Pumping 
Piezoelectric pumping was accomplished using a AB1290B-LW100-R ceramic 
piezoelectric buzzer on a 12.3mm brass disc (DigiKey, Thief River Falls, MN), powered 
by an HP 33120A signal generator and connected via a Model 7500 10x voltage amplifier 
(Krohn-Hite, Brockton, MA) to provide an excitation voltage in the range from 30-100V 
at frequencies from 50-150Hz. The signal generator controls were used to set the AC peak-
to-peak voltage amplitude and frequency and connected to the amplifier. The output of the 
amplifier was connected directly to the piezoelectric buzzer leads. The buzzer was set into 
fluidic chips using dry-film adhesive (3M) and sealed into place with a carefully applied 
ring of two-part epoxy (Loctite). All fluidic chips were fabricated a circular chamber that 
matched the dimensions of the piezoelectric buzzer and with no-moving-parts (NMP) 
valves fabricated on either side to create flow rectification. Two designs of NMP valves 
were utilized: a simple nozzle designed to compress laminar flow on one side and create 
turbulent flow on the other, and a recirculating nozzle designed to amplify that effect[319, 
320]. 
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3.3.5 Bacterial Culture 
Stbl3 Escherichia coli (ThermoFisher, Waltham, MA), a variant of the HB101 strain, were 
transformed using the pUC19 plasmid (ThermoFisher) for selection by ampicillin. 1µL of 
concentrated pUC19 plasmid were injected into a prepared hot-shot vial of E.coli, and 
mixed by gently turning the vial back and forth. The E.coli were allowed to incubate at 
room temperature with the plasmid for 30m before injecting 4µL into a prepared vial of 
2mL LB Broth and 100µg/mL ampicillin. The vial was then incubated at 37C in a Model 
10-140 Incubator (Quincy Lab, Chicago, IL) for two days to allow the ampicillin resistant 
bacteria to grow. The bacteria were then centrifuged for 1m at 2000g to form a pellet. The 
pellet was resuspended in 100µL of LB Broth, and then mixed with 100µL of 50% LB 
Broth, 50% glycerol prior in a screw-cap vial prior to storage at -20C. 
3.3.6 DNA Isolation Protocol 
DNA solutions were prepared from Stbl3 E.coli transformed with the pUC19 plasmid 
(Sigma Aldrich, St. Louis, MO). Bacteria were grown in an incubator at 37C for two days 
in LB Broth containing 100µM ampicillin prior to harvesting and centrifugation. The 
resulting bacteria were then lysed and DNA was isolated using a DNEasy Blood and Tissue 
Kit (Qiagen) for solid phase extraction and purification of DNA. DNA samples were then 
analysed using a NanoDrop (ThermoFisher) to determine concentration and verify purity. 
3.3.7 PCR Protocol 
Two PCR mixes were used for the experiments in this chapter. The first was TopTaq 
Master Mix (Qiagen), and the second was AmpliTaq Gold Fast Master Mix 
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(ThermoFisher). Experimental solutions consisted of 1X Master Mix, 500nM DXS forward 
primer 5’-CGAGAAACTGGCGATCCTTA,, Sigma Aldrich), 500nM DXS reverse 
primer (5’-CTTCATCAAGCGGTTTCACA, Sigma Aldrich) and DNA solution prepared 
from the bacterial lysate at final concentrations ranging from 5pg/µL to 5ng/µL in 
deionized, RNase and DNase pure water. All solutions were prepared fresh just prior to 
thermocycling. The PCR protocol utilized depended on the master mix used. For TopTaq 
master mix, a cycling protocol of 30s at 94C, 30s at 60C and 1m at 72C for 40 cycles was 
used. For AmpliTaq Gold Master Mix, an initial hot start step of 10 min at 95C was used, 
followed by a cycling protocol of 3s at 96C, 3s at 60C and 10s at 68C for 35 cycles. 
3.3.8 Agarose Gel Electrophoresis 
Agarose gels were prepared using UltraPure Agarose (Invitrogen, Carlsbad, CA). 1g of 
agarose was added to 50mL of 0.5x Tris-Acetate-EDTA buffer and heated using a 
microwave oven until the agarose powder fully dissolved into solution. The resulting 2% 
agarose solution was then poured into a gel casting mold. The gel was allowed to cool until 
it had firmly set, and then was stored in 0.5x TAE buffer until needed for use. In a typical 
electrophoretic experiment, samples were incubated in 1X SybrGreen for 30 minutes to 
allow the dye to intercalate into any DNA present in the sample. 2µL of bromophenol blue 
tracking dye (10X BlueJuice, Invitrogen) was then added to 20µL sample aliquots just prior 
to loading into the wells of the agarose gel by pipette. Agarose gel electrophoresis was then 
performed at 100V on a JouleBox electrophoresis system (Stratagene, San Diego, CA) with 
the anode at the base of the gel until the tracking dye neared the end of the gel. The gels 
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were then photographed using either a BioRad transmission UV plate reader or an 
UltraLum UV Transilluminator. 
3.4 RESULTS 
3.4.1 Disk/Cartridge Based PCR 
With Polymerase Chain Reaction (PCR) as an ideal starting point for detection of 
genetic resistance markers in bacterial samples in a microfluidic setting, the first step was 
to develop a system for rapid thermocycling that could be used in conjunction with 
fluorescent imaging of DNA intercalated with a dye molecule such as SybrGreen or 
EvaGreen – DNA specific dyes commonly used in real-time PCR (qPCR). The initial 
design paradigm was based on the premise of a disk-based fluidic chip 3D printed using a 
powder-based Z-Printer (Z-Print) for low-cost assembly (Fig. 3.1). The design utilized a 
series of wells that could be connected to channel structures for centrifugally controlled 
flow of reagents. With reagents and DNA samples loaded into the wells, the disk would 
rotate the wells between three ‘oven’ zones heated by metal thin-film heaters controlled by 
a resistance thermal detector (RTD) connected to a Basic Stamp control board. A similarly 
3D-printed tray for the disk was used to house the heating elements. The tray was coated 
in Teflon spray in order to minimize friction from the rough surface. 
Early testing of this design demonstrated that the use of Z-Printed materials was 
not viable for microfluidic design – rough surfaces and high porosity led to poor flow in 
channel structures, and liquid samples were absorbed into the surface during PCR 
experiments.  
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Figure 3.1. CAD diagrams of early disk and cartridge-based PCR system components. A) Stacked 
diagrams of test PCR disk with sample wells, disk tray with slots for central spindle, camera, and 
thermistor mounting, and central spindle for rotation of the disk using stepper motor control. B) 
Diagram of heater assembly with minimal material between oven zones to reduce thermal bleed. 
Kapton thin-film heaters were adhered into the base of chambers, with slots in the sides for 
thermistor leads. During construction, all gaps were sealed to create airtight chambers. C) Stacked 
diagram of cartridge-based PCR system, with 3D printed oven and stage assemblies surrounding a 
cartridge constructed from laser etched PMMA with wells and a slot to act as a track for a 
thermistor. 
 
 
 Following these results, the use of 3D-printed materials was discontinued for PCR 
chips – surface roughness and high porosity were found to be a hallmark of 3D-printed 
structures from all but prohibitively expensive photopolymer printers. The disk based 
design was also set aside due to a lack of planned utility for the capabilities of centrifugal 
force and the significant unnecessary design considerations required for it to function. A 
cartridge-based design that could be loaded into a desktop device was selected for the 
next design paradigm (Fig. 3.1C). A similar assay design was utilized – a series of wells 
patterned into a thin polymethylmethacrylate (PMMA) cartridge which could then be 
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moved on a ratcheted gantry between three oven zones set to PCR temperatures with 
fluorescent detection through a custom optical system. 
Testing on the cartridge-based thermocycling chip design revealed that in the 
absence of absorption effects from chip materials, the oven-based design was inadequate 
for successful PCR, resulting in no detectable fluorescence bands following gel 
electrophoresis. Notable design failings included significant temperature lag due to the 
insulating effect of PMMA (0.18 W/mK thermal conductivity), and difficulty sealing the 
oven zones in the mobile system that led to waste heat and difficulty maintaining the high 
temperatures required for the DNA denaturation step of PCR. 
3.4.2 Thermoelectric Thermocycling 
 To address the failings of the cartridge thermocycling design, another paradigm 
was adopted. Instead of utilizing a series of ovens for temperature control, a single 
thermoelectric heating element (TEC) was used in contact with a PCR microchip 
containing sample wells, controlled using a custom circuit described in the appendices. In 
short, an Arduino Uno control board connected to an L6203 relay (DigiKey) was used to 
regulate input current from a 24V, 4A power source (NG60-5, BioTec) to a VT-127-1.0-
1.3-7.1 30mmx30mm Peltier device (TE Technology, Traverse City, MI). The 
thermoelectric (Peltier) heating element allowed for rapid cooling in addition to heating, 
by far the most time-consuming step in traditional PCR systems. In order to minimize 
temperature lag between the TEC and the sample inside the microchip, it was decided to 
use a material with a high thermal conductivity as the base substrate. To this end, potential 
chip construction materials were tested for PCR inhibition with and without the presence 
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of bovine serum albumin, a common PCR adjuvant for increasing biocompatibility of 
substrates. Fig. 3.2 shows the results of these experiments. 20µL PCR samples, each with 
50ng of E.coli DNA were prepared with primers for the DXS target gene, loaded into 
200µL tubes and covered with 10µL of mineral oil. A small piece of test material was then 
loaded into each tube prior to undergoing PCR in an Eppendorf thermocycler. The 
materials tested were aluminum and copper as thermally conductive substrates (205 and 
385 W/mK respectively), PMMA and dry-film adhesive (3M). The samples including 
aluminum, BSA coated PMMA and the adhesive all resulted in positive PCR results, while 
the copper (both conditions) and uncoated PMMA were both found to inhibit PCR.  
 
 
Figure 3.2. Results of agarose gel electrophoresis on samples incubated with 1x SybrGreen 
following PCR performed on an Eppendorf Thermocycler during incubation with various materials, 
with and without the presence of bovine serum albumin (BSA). All samples tested showed positive 
PCR results with the exception of copper, which demonstrated PCR inhibition regardless of BSA. 
 
 Due to the inhibitory effect demonstrated by copper on PCR, a test chip for the TEC 
thermocycler was constructed from 36-gauge aluminum form-pressed into wells and 
adhered to a band of BSA coated PMMA by dry-film adhesive to allow for a layer of 
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mineral oil to prevent evaporation (Fig. 3.4A). This chip was then placed into contact with 
the TEC via a thin layer of thermal paste (Tuniq, Taiwan).  
To handle temperature control, two approaches were tested. First, an infrared 
thermal sensor designed for use with a BasicStamp control board aimed at the aluminum 
wells, and second, a 1kΩ RTD (DigiKey) was utilized in a wheatstone bridge 
configuration, connected to an op-amp to achieve a 10-fold voltage increase on input to an 
Arduino Uno control board (see appendix for circuit diagram). Custom PID (proportional-
integral-differential) control software was written for the Arduino Uno control board 
utilizing the RTD as a thermal sensor (see appendix for code). PID control constants were 
tuned experimentally to achieve stable ramping and temperature control with minimal 
overshoot and oscillation.  
To verify the calibration of the thermal sensors and ensure proper PCR 
thermocycling, a melt test was performed. Microchip wells were filled with compounds 
with known melting points close to common target temperatures for PCR thermocycling, 
P-bromophenol (Tm = 66.4C), 2-Nitroaniline (Tm=71.5C) and Benzil (Tm=95C). A fourth 
well was filled with deionized water to determine the measured temperature at boiling. A 
program was set up to hit each of these temperatures and hold for 30 seconds in series and 
adjusted until the appropriate compound began to melt while held at temperature. Table 
3.1 shows the measured temperatures from both the RTD and the IR sensor at the melting 
points of each compound, and the boiling point of water. The RTD measurement was 
consistently slightly high, ranging from 1-3 degrees above the target, likely due to the 
placement in contact with the TEC surface creating a differential with liquid samples in the 
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microchip wells. Microchip wells were filled with deionized water, and heated. During 
heating, both sensors were monitored and compared to each other as well as observed 
temperature when the water in the wells began to boil. Table 3.1 shows the relative 
temperatures measured during several points in heating, as well as when the water sample 
began to boil. The IR sensor consistently resulted in temperatures 10-15 degrees lower than 
the RTD placed on the TEC surface. The RTD also proved significantly more accurate 
during the boiling test. This was likely due to a combination of interference from the layer 
of mineral oil coating the well structure reducing the measured temperature from the IR 
sensor, and the high reflectivity of aluminum to IR signals. As a result, the RTD sensor 
was used in all further experiments. The target temperatures for PCR were adjusted to 
account for the differences between measured and actual results. 
 
Table 3.1. Temperature calibration table for infrared thermal sensor and resistance thermal detector 
(RTD) using phase changes of compounds with known transition points. Data points represent 
approximate measured temperatures (+/- 1C) at which the transition point was observed for each 
sensor. 
 P-Bromophenol 
Melt (66.4C) 
2-Nitroaniline 
Melt (71.5C) 
Benzil Melt 
(95C) 
Water Boil 
(100C) 
IR Sensor 50 55 84 87 
RTD 67 73 97 102 
 
  
Once the temperature measurements were verified, the stability of the system was 
tested. The thermocycling program was adjusted to utilize the target temperatures and 
timing of the TopTaq PCR protocol (Qiagen, Hilden, Germany), microchip wells were 
filled with deionized water, and the system was allowed to run for a 40 cycles. To test for 
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gradients across the TEC in this experiment, a second RTD was placed on the other side of 
the TEC and measured for the same period. Figure 3.3 shows an average cycle for timing 
of temperature changes, and the stability of holding at each target temperature for both 
RTDs. The time between temperature points was found to be 3s from 72 to 95C, 3s from 
95 to 65C and 2s from 65 to 72C, much lower than that from the Eppendorf thermocycler, 
with comparable cycles of 22s, 34s, and 14s, respectively. A slight gradient of 
approximately one degree was observed between the two measured RTDs, but this was 
within the margin of error (~5% tolerance). The control program also resulted in 
temperatures consistently within 0.5C of target temperatures (Fig. 3.3B).  
 
 
Figure 3.3. A) Measured temperature at two points on the chip surface over time during a PCR 
cycle with TopTaq protocol. RTD1 measurements were used for control of the PID heating system. 
B) Histogram of thermal stability at each step as measured over the course of 40 cycles. Error was 
consistently within 0.5 degrees of target temperature, with a slight positive bias (~0.1C) at the 
denaturing step. 
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 With both temperature measurement and stability of thermocycling verified, a PCR 
test was run utilizing TopTaq master mix and primers for the E.coli DXS gene. 20µL 
samples including 50ng each of E.coli DNA were prepared and pipetted into the wells of a 
freshly prepared and autoclaved microchip. The PID control program was run for 40 cycles 
to allow for adequate thermocycling. Simultaneously, identical samples were run using an 
Eppendorf thermocycler as a positive control. Following completion, the samples were 
incubated with 1x SybrGreen dye for 30 minutes and loaded onto a 2% agarose gel with 
bromophenol blue tracking dye. Fig. 3.4C shows the resulting gel following reading on a 
BioRad Transmission UV gel reader. The TEC thermocycler resulted in a DNA band 
comparable to that of the Eppendorf system, indicating successful PCR. 
 
Figure 3.4. A) Cross-section of well-based PCR chip. 3M dry-film adhesive (100um) used to bind 
components. B) Image of PCR chip set on TEC thermocycler. Thermal paste used to maximize 
heat transfer between TEC, aluminum wells and RTD sensor. RTD localized to external edge of 
well 1. C) Agarose gel electrophoresis of PCR results from TEC thermocycler wells and BioRad 
iCycler iQ for positive control following incubation for 20m with 1x SybrGreen dye. 
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 Following verification of the thermocycling assembly using simple wells for PCR, 
a new microchip design was implemented to test for flow-through PCR in order to reduce 
the time required for analysis of clinical scale samples (~2mL) and allow for sample 
preparation systems and other assays to be added to the system in future work. To 
accomplish this, a channel-based design was utilized. Two primary designs were 
considered. In both cases, a consistent cross section for the microfluidic channel was 
maintained at 300µm depth and 2mm width (Fig. 3.5). For the first design, the channel 
structure was formed from pressed aluminum adhered to BSA-coated PMMA by dry-film 
adhesive (Fig.3.5D), and in the second the channel structure was prepared from layered 
dry-film adhesive between flat layers of 36-gauge aluminum and BSA coated PMMA (Fig. 
3.5B). 
 
Figure 3.5. A) Top-down diagram of continuous flow PCR test chip. 2mmx0.2mm cross section 
either formed from pressed aluminum or cut from 3M dry film adhesive. PMMA Substrate used 
for top of chip, with inlets cut for 0.062”OD PEEK tubing. B) Cross section diagrams for channel 
structures formed from 3m DFA (left) and pressed aluminum (right). C) Image of pressed 
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aluminum channel test chip on TEC Thermocycler. Input tubing fed from KD100 syringe pump, 
output to sample collection tube. 
 
 To verify that these designs were functional, they were utilized for PCR on the TEC 
thermocycler using the SybrFast master mix protocol (ThermoFisher, Waltham, MA). 
200µL of PCR sample were prepared as described above, including 250ng of DNA to 
maintain consistent concentration, and loaded into the microchip for thermocycling. While 
the SybrFast protocol calls for a 10 minute heating step for hot-start, this was not used for 
the microchip thermocycling to simulate continuous flow conditions in which a hot start 
could not be included on the TEC. Fig. 3.6A shows the resulting gel utilizing the microchip 
with channel structures cut from the dry-film adhesive. While the PCR was successful, the 
resulting bands were faint – likely due to the lack of a hot-start cycle in the experiment. 
 To confirm this, a second set of verification experiments were performed using the 
AmpliTaq Gold master mix protocol (ThermoFisher, Waltham, MA), chosen for both 
speed of thermocycling (16 seconds for an ideal cycle) and lack of SybrGreen in the 
reaction mix as an unnecessary complicating factor. First, the shortest necessary hot-start 
period was determined using an Eppendorf thermocycler. Seven 20µL samples were 
prepared using the AmpliTaq Gold master mix, primers for the E.coli DXS gene and 50ng 
of E.coli DNA each. One sample was placed into the thermocycler at the start of the 10 
minute recommended hot-start period, and the others were added with 5m, 4m, 3m, 2m, 
1m, 30s and 0s remaining. The resulting samples were run on a 2% agarose gel, which is 
shown in Fig. 3.6B. The minimum necessary hot-start time period for successful PCR using 
this reaction mixture was found to be two minutes. To allow for a safety margin, the PID 
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controller for the TEC thermocycler was set for a hot-start period of 240 seconds. A 200µL 
PCR sample was prepared using the same proportions as those used on the Eppendorf 
thermocycler and loaded into a microchip and run for 35 cycles on the TEC thermocycler. 
The resulting samples were then run on a 2% agarose gel and read using an UltraLum UV 
Transilluminator (Fig. 3.6C). Since successful PCR was achieved with this chip design, the 
pressed aluminum chip was discontinued due to the rounded channel edges achieved and 
difficulty in preventing tears. 
 
Figure 3.6. Gel electrophoresis results for PCR output from TEC Thermocycler compared to 
Eppendorf commercial thermocycler following incubation for 20m with 1x SybrGreen dye. A) 
SybrFast PCR protocol, all samples for TEC Thermocycler performed without hot-start activation 
step. B) Minimum Hot-start time verification performed on Eppendorf MasterCycler Gradient. 
Minimum hot-start period with no loss in PCR signal was two minutes. C) AmpliTaq Gold PCR 
protocol, including hot-start activation step, performed on TEC thermocycler and Eppendorf 
MasterCycler Gradient. 
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3.4.3 Pumping and Flow Control Systems 
 Multiplex detection is necessary for any rapid characterization of resistance 
markers in a bacterial sample due to the multitude of such markers to test for and the range 
of possible bacterial species. As a result, DNA hybridization array detection was selected 
as an ideal readout for the device due to its sensitivity[244] and strong compatibility with 
PCR. DNA probes are generally 20-30 nucleotides in length, however, resulting in melting 
temperatures between 70-80C, which would make consistent measurement in a 
thermocycling region impossible – thus limiting real time PCR in a continuous flow 
detector. This effect can be used for advantage, however – nearing the melt point of a DNA 
probe reduces the likelihood of mismatch and non-specific binding, resulting in much 
greater specificity of a hybridization array located spatially close to a thermocycling 
region[321, 322]. 
 To utilize this effect, a novel design paradigm was implemented in which a looped 
section was utilized consisting of the thermocycling zone localized directly above the TEC 
thermocycler, and a DNA hybridization detection zone outside, but spatially near the 
thermocycler. In order to allow for a continuous flow system with such a design, an 
integrated pumping system in the loop to maintain flow separate from the main flow in the 
device was required. The system needed to be fully located within the volume of the loop 
to prevent excess volume from being external to the thermocycling zone, which could lead 
to primer-dimer effects due to significant temperature drop[151], as well as longer PCR 
times. Four potential in-channel pumping regimes were considered: electrokinetic (EK), 
electroosmotic (EO), pneumatic and acoustic pumping. While EK and EO pumping both 
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maintained the advantage no moving parts, pumping speed was heavily dependent on ionic 
strength of the solution – a factor that could not be considered consistent in clinical samples 
– and resulted in low flow rates even at ideal conditions (<10µL/m). Pneumatic pumping 
required both significant use of moving parts that could break down, as well as the use of 
a deformable substrate such as PDMS that could lead to bubble formation under PCR 
conditions. Acoustic pumping (also known as piezoelectric, Fig. 3.7) utilized minimal 
moving parts while still maintaining high flow rates, so further experimentation was 
performed using this regime. 
 As the acoustic pumping system relied on flow rectification to create a net flow in 
one direction, the design of the required no-moving-parts (NMP) valves was considered to 
maximize flow profiles. Two main designs were considered for the NMPs utilized in flow 
rectification (Fig. 3.7B): a nozzle-NMP (nNMP), a simple constricture designed to 
constrict laminar flow before a sudden opening[323], leading to turbulent flow on the other 
side to create a flow differential; and a recirculation NMP (rNMP), a series of constrictures 
and openings designed to increase the flow differential in the two directions through 
multiple layers of laminar/turbulent flow shift[319, 320]. 
 
 57 
 
Figure 3.7. A) Operational principle diagram of piezoelectric pump. No-moving part (NMP) valves 
used to rectify flow created from deflection of the piezoelectric buzzer. Flow enters the chamber 
when the buzzer deflects upwards, and out when it deflects downwards. The NMP valves each limit 
flow in one of these directions, leading to a net flow through the pump. B) Fluidic NMP valve 
designs, nozzle (top left), recirculating (bottom left), Tesla Valve (right, reproduced from 
Thompson, et al)[324]. C) Image of a test chip for piezoelectric pumping flow. Channel structures 
cut from 3M dry film adhesive (200µm) between layers of PMMA. Nozzle NMP design used for 
this chip. 
 
 
 In order to compare the two designs, looped flow chips were fabricated from 
PMMA with channel structures cut from a 300µm layer of dry-film adhesive to mimic the 
structure of thermocycling PCR chips used (Fig. 3.7C). One each was prepared for the two 
NMP designs. A series of marks were etched into the surface of the PMMA at 1mm 
intervals using a CO2 laser to serve as a ruler. The chip was then filled with deionized water 
mixed with a small quantity of 45µm diameter silicon microbeads and placed under a Zeiss 
microscope. The etched ruler region was placed in focus, and the piezoelectric buzzer was 
activated with a signal generator and the ruler zone recorded. First, the frequency was 
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modulated from 50-150Hz and the flow rate measured by calculating the velocity of 
microbeads through the ruler zone at 70V input(Fig. 3.8A). The maximum flow rate was 
found to occur at a signal frequency of 110Hz for both nNMP and rNMP, though the nNMP 
had a significantly higher flow rate. The frequency was then set to 110Hz, and the voltage 
modulated from 30-100V and the results recorded as before for both nNMP valve (Fig. 
3.8B) and rNMP valve (3.8C). Due to its higher flow rate, the nNMP was chosen for future 
usage, with a 70V input to match a desired flow rate of 160µL/m in the PCR loop. 
 
Figure 3.8. A) Flow rate generated from piezoelectric pump at 70V for nozzle and recirculating 
NMP valve designs at frequencies from 60 to 160Hz. Maximum flow rates occurred at 110Hz for 
both valve designs, resulting in a peak of 162µL/m for the nozzle valve, and 40µL/m for the 
recirculating valve. B) Pumping flow rate for nNMP valve by voltage while frequency was held 
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constant at 110Hz. Maximum attained flow rate was 300µL/m, well above desired in-loop flows. 
C) Pumping flow rate for rNMP valve by voltage while frequency was held constant at 110 Hz. 
Flow rate appeared to plateau at a maximum of approximately 60µL/m. 
 
3.4.4 PCR Verification 
 While acoustic pumping proved ideal for consistent and tunable flow rate regardless 
of solution ionic strength, the requirement for a piezoelectric buzzer carried some risks for 
PCR – nearly all piezoelectric buzzers use brass as the deflecting metal, and as brass is an 
alloy of copper and tin, it carries copper ions that can inhibit PCR. To test if this concern 
was warranted, 20µL PCR samples utilizing AmpliTaq Gold master mix, primers for the 
E.coli DXS gene and 50ng of E.coli DNA were loaded into tubes with small slivers of brass 
cut from a piezoelectric buzzer, uncoated and coated with BSA. As shown in Fig. 3.9A, 
the brass was found to inhibit PCR, both coated and uncoated.  
In order to avoid this problem, three potential modifications were made to avoid 
contact between the brass and PCR solution while maintaining the flexibility required for 
pumping: coating the brass with a layer of dry-film adhesive, with a layer of dry-film 
adhesive followed by a layer of aluminum foil (0.016mm), and a PDMS coating. The 
experiment was then repeated with each of these conditions. As shown in Fig. 3.9B, all 
three treatments resulted in successful PCR, though the dry-film adhesive alone, and 
PDMS both resulted in a broadened DNA band on the gel indicative of damaged product.  
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Figure 3.9. Gel electrophoresis results for PCR samples following incubation for 20m with 1x 
SybrGreen Dye. A) Samples incubated with brass and BSA-coated brass during PCR on Eppendorf 
thermocycler. In both cases, copper ions leached from the brass inhibited amplification. B) Test 
series for buzzer coatings to prevent PCR inhibition. Dry film adhesive (3M) was used for adhesion 
to buzzer and subsequently coated with nothing, polydimethylsiloxane (PDMS) and aluminum 
(0.016mm). All three resulted in amplification, though DFA alone and DFA/PDMS coatings 
resulted in broken products. C) On-chip PCR results from TEC Thermocycler while undergoing 
piezoelectric pumping with a buzzer coated in DFA and aluminum. 
 
 
 As a result, the piezoelectric buzzer was coated with a 100µm layer of dry-film 
adhesive, followed by aluminum foil and placed into a thermocycling chip. The chip was 
then loaded with 200µL of PCR sample utilizing AmpliTaq Gold master mix, primers for 
the E.coli DXS gene and 2.5ng/µL of E.coli DNA. The chip was then placed on the TEC 
thermocycler and run for 35 cycles while under acoustic pumping at 70V and 110Hz. Fig. 
3.9C shows the results after incubating with SybrGreen and loading onto a 2% agarose gel. 
The strong DNA bands indicated successful PCR, and thus prevention of contamination by 
copper ions from the brass disc in the piezoelectric buzzer. 
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3.5 DISCUSSION 
 Polymerase chain reaction serves as an ideal assay for characterization of bacterial 
resistance markers due to its applicability to a wide range of genetic sequences with extant 
probe panels designed for detecting common pathogens and resistance markers, in addition 
to ease of multiplexing and translatability of a thermocycling design to other assays such 
as HDA and LAMP. While these strengths have led to the ubiquity of PCR as a gold 
standard in pathogen characterization, it also carries a number of unique challenges for a 
microfluidic system. These include precise temperature control and prevention of thermal 
gradients, material properties under high temperature, microbubble prevention and high 
pressure under heating in a microchamber. 
 As discussed in this chapter, a number of design approaches were undertaken to 
address such potential failure modes. Rough surfaces, such as those from 3D-printed 
materials were found to contribute to microbubble formation due to interfacial trapping at 
channel walls during sample loading, air heated oven designs resulted in significant 
temperature lag in enclosed chips due to low thermal conductivity of transparent substrates. 
Open well systems avoided this constraint as well as high pressure under heating, but 
required separate loading of reagents into wells and a mineral oil layer to prevent 
evaporation. 
 TEC mediated heating using an RTD for temperature measurement and control 
resulted in rapid and accurate thermocycling that could be applied to an enclosed 
microfluidic structure fabricated with a highly thermally conductive substrate such as 
aluminum. With careful use of dry-adhesive film as a bonding agent and externally applied 
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pressure, leaks due to spikes in microchip pressure were avoided leading to successful 
thermocycling as demonstrated by fluorescent measurement of DNA intercalating dyes. 
Temperature control was tuned to prevent temperature overshoot and characterized, 
demonstrating minimal time between PCR steps and consistent thermal stability within 
0.5C of target temperatures. 
 To minimize assay time for clinical samples, a continuous-flow microchip design 
was implemented and adapted to a looped thermocycling system with built-in hybridization 
detection zone for real-time measurements with strong binding specificity. In-line pumping 
strategies were evaluated to allow for separated control between the loop and overall device 
flow. Piezoelectric pumping was selected for minimal moving parts and rapid net flow 
profiles. Characterization of this pumping regime demonstrated maximum achievable flow 
rates in excess of 120µL/m, well above the desired 80µL/m loop internal flow rate. 
 A fully constructed thermocycling loop microchip with built-in acoustic pumping 
was demonstrated and successful PCR was verified under an internal pumping rate of 
80µL/m using measurement of DNA intercalating fluorescent dye following gel 
electrophoresis. DNA band strength was found to be comparable to that resulting from an 
Eppendorf Thermocycler. This opened the way for development of a loop-internal DNA 
hybridization array for multiplex PCR detection.  
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CHAPTER 4: 
Digital Micromirror LSPR Imaging and Optimized Tunable 
Nanoprism Synthesis 
4.1 ABSTRACT 
 Even with Polymerase Chain Reaction (PCR) mediated amplification of DNA, 
highly sensitive detection is required to attempt to detect the lowest possible concentrations 
of DNA, resulting in both more rapid detection and sensing of low concentration targets. 
While fluorescence quantification is standard for sensitive DNA hybridization systems, the 
need for floating label molecules in the reaction mix that can inhibit PCR and complicate 
the system. In this regard, nanoparticles provide a solution: localized surface plasmon 
resonance provides a highly sensitive, label-free detection regime that couples well with 
DNA hybridization mechanics through 5’-thiol modified DNA probes. While LSPR holds 
many attractive properties, it is underutilized in microfluidics, likely due to the difficulties 
inherent in nanoparticle synthesis, tuning, and optical interrogation. 
 In this chapter, silver nanoprism synthesis is optimized to achieve stable, 
monodisperse colloids capable of thiol-binding for easy adhesion to glass substrates – 
important not only for LSPR applications described here, but also SERS and Raman 
Scattering. Numerous synthesis techniques have been reported, but the influence of 
reagents on reproducibility and stability of nanoplates has not been characterized. We 
studied a citrate-stabilized, peroxide-based synthesis of AgNPrs and demonstrated that 
concentration of secondary reducing agent is critical to AgNPr stability. We further 
demonstrated that varying the concentration of sodium citrate in the seed solution, dilution 
factor, and rate of silver nitrate addition can be used to tune nanoprisms with a wide variety 
of sizes and narrow absorption peaks while still allowing functionalization with thiol-
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binding. These findings will allow for more precise control of chemical AgNPr synthesis 
for solution and surface-based plasmonic applications. 
 Additionally, we demonstrated the development, characterization and optimization 
of a low-cost spectroscopic imaging system for LSPR utilizing spatial diffraction onto a 
digital micromirror device to generate frequency discrimination. The resulting device 
achieved 2nm resolution across a band of light from 560-640nm, capable of taking a 
spectral image in 40 seconds for a spot size of 3.3mm diameter. The system was able to 
strongly resolve spectral changes under treatment of nanoparticle layers with different 
dielectric solvents, demonstrating potential for detection of DNA hybridization events. 
4.2 INTRODUCTION 
 While the results of the previous chapter described a microfluidic thermocycling 
chamber with potential for in-channel real-time detection, the actual detection system was 
left nebulous. While a number of microfluidic detection methods have been demonstrated 
for DNA, including hybridization[325], and electrochemical effects[326], simultaneous 
detection of multiple targets in a multiplexed assay necessitates the use of probes specific 
to targeted DNA sequences. In this situation, hybridization arrays are the gold standard – 
spatial separation of target-specific probes immobilized on a surface to allow parallel 
detection of a large number of target molecules[247]. 
 Classically, DNA hybridization arrays utilize fluorescent markers for detection – 
hairpin probe sequences maintain a fluorescent marker covalently linked to a quencher, 
which are then cleaved by DNA binding events. While this approach is simple and lends 
itself well to optical detection, it lacks in sensitivity and has limited specificity – once the 
bond between marker and quencher is cleaved, even by non-specific binding, it cannot be 
reformed[327]. This can be avoided by use of labeled markers in the reaction solution that 
 66 
bind to the probe-target sequence complex, but adds an additional layer of complexity and 
floating labels can contribute to primer-dimer errors during PCR amplification. 
 A number of alternative approaches to detection of hybridization events have been 
studied in recent years, including electrochemical measurements[326], molecular 
transistors[248], and plasmonic systems[249, 250]. Of particular interest are plasmonic 
approaches, utilizing the unique properties of noble metals to measure target binding. As 
demonstrated for surface plasmon resonance (SPR), thin layers of noble metals (gold, silver 
and copper) can couple the evanescent field of totally-internally-reflected (TIR) light into 
surface waves known as plasmons at a characteristic reflection angle for each wavelength 
of incident light that changes with the local dielectric constant on the other side of the noble 
metal surface – allowing for highly sensitive detection of changes in mass of biomolecules 
in close proximity to the surface, such as DNA targets binding to probes[48]. 
 Localized Surface Plasmon Resonance (LSPR) serves as an extension of these 
findings – noble metal nanoparticles have a strong extinction at characteristic wavelengths 
of light in the visual to near-infrared range, depending on the size and shape of the 
particle[49, 266]. As with SPR, this extinction peak shifts with changes in the local 
dielectric constant, allowing for measurement of hybridization effects among many other 
potential assays. Whereas SPR requires a complex prism configuration for precise angles 
and TIR, LSPR measures direct extinction of light passing through a nanoparticle 
monolayer, greatly simplifying the necessary optical pathway. With 2D spectroscopic 
analysis, LSPR can be used for imaging of a hybridization array for highly sensitive 
detection[271]. 
The use of LSPR imaging in a potentially noisy system such as that present in a 
microfluidic system relies on the strength of extinction peak shift of the nanoparticles 
adhered to the substrate when the local dielectric constant changes. Shaped nanoparticles 
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with sharp edges or corners, such plates, cubes, prisms and nanoholes significantly increase 
the local electric field at these points, leading to a marked increase in the optical shift[54]. 
Due to their greatly improved optical properties over spherical particles, triangular 
nanoprisms are commonly used for SERS and LSPR applications[49]. While any of the 
noble metals carry the necessary properties for LSPR, gold and silver offer the strongest 
responses. Silver nanoplates offer a stronger spectral response than gold, but can be more 
difficult to synthesize and cannot be utilized in vivo due to their natural toxicity[328]. As 
a result, silver nanoprisms are ideal for in vitro analysis where toxicity is not a concern. 
 There are numerous techniques currently described for synthesizing silver 
nanoplates, ranging from the photoinduced[288] methods to solvo-thermal[298] and 
seeded growth[301]. In virtually all synthesis techniques, a simple reduction reaction is 
first used to synthesize small silver nanospheres (3-5nm diameter), after which varying 
approaches are taken to reach a nanoplate structure. For photoinduced methods, a ligand 
(BSPP) is used to sequester silver ions from the bulk reaction and slowly release them over 
time under a laser tuned to the dipole moment of the desired size of nanoprism. A second 
laser tuned to the quadrupole can be used to isolate a specific size rather than two 
bands[297]. These techniques are well studied and produce a relatively monodisperse 
sample, though they suffer the drawback that the necessary ligand is believed to inhibit 
particle functionalization due to strong adhesion to the particle surface. 
 Solvo-thermal techniques avoid the problem of surface binding ligands, instead 
relying on thermodynamic control to tune the final shape of the particles. These techniques 
rarely result in monodisperse samples and can be difficult to control without precision 
equipment. Seeded growth techniques utilize an etchant, such as hydrogen peroxide, in 
combination with a second weaker reducing agent and a surface stabilization agent to 
induce directional growth of nanoparticles under slow addition of silver ions, with final 
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size depending on the amount of silver added[300]. These techniques rely on the ratios of 
etchant/reducing agent as well as the stabilization agent used to control the reaction. For 
the purposes of an LSPR imaging based biosensor, a monodisperse sample of nanoprisms 
with strong edges resulting in a narrow absorption peak is critical. The particles must also 
be functionalizable and be stable over time to allow for storage. 
 This chapter enumerates both the selection and optimization of silver nanoprism 
synthesis with an eye towards use in an LSPR imaging system, as well as the design and 
testing of a low-cost optical system for 2D spectroscopic imaging of nanoparticle 
monolayers. Optimization of silver nanoprism synthesis was accomplished by 
interrogating the effects of reagents and conditions on particle stability, functionalizability, 
and optical properties to obtain prisms with strong absorption peaks capable of thiol-
binding to substrates and probes. An optical imaging system using diffracted light and a 
digital micromirror device to achieve spectroscopic images was constructed and evaluated 
for strengths and weaknesses, and potential for detection of DNA hybridization events 
following PCR amplification in a microfluidic system. 
4.3 MATERIALS AND METHODS 
4.3.1 Silver Nanoprism Synthesis 
Prior to synthesis, all reagent solutions were prepared fresh – sodium borohydride 
and L-ascorbic acid are reducing agents and thus lose reduction potential over time due to 
oxidation. In a typical experiment, a solution consisting of 39.3mL diH2O, 2mL Trisodium 
Citrate (TSC) (75mM), 256µL Hydrogen Peroxide (H2O2) (0.6%), 186µL Silver Nitrate 
(AgNO3) (10mM) was prepared (Sigma Aldrich, St. Louis, MO). Under vigorous stirring, 
192µL of Sodium Borohydride (NaBH4) (100mM) (Sigma Aldrich) was rapidly added to 
initiate reduction, and the solution immediately changed to a pale yellow color. After about 
five minutes, the color shifted to a golden yellow. After this color shift, the solution was 
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stored overnight at room temperature to allow the NaBH4 to complete its reduction. 
Following this aging period, 2.1mL of the seed stock were added to a clean 8mL vial and 
stirred vigorously. 200µL of L-Ascorbic Acid (5mM) (Sigma Aldrich) were added to this 
mixture, followed by addition of AgNO3 (10mM) dropwise until the solution reached a 
color indicative of desired nanoprism size (i.e. purple for ~35nm edge length particles with 
an extinction peak at 550nm) was reached (typically 100µL).  
When performing flow rate experiments to determine the optimal conditions for 
nanoprism synthesis, a modified version of the above protocol was used. Seed stock was 
prepared as before, after which 2.1mL of the seed stock were added to a clean 8mL vial 
and stirred vigorously. 200µL of L-Ascorbic Acid (5mM) were added to this mixture. A 
KD Scientific syringe pump was then used to inject 100µL of AgNO3 at a controlled rate 
(between 15µL/min and 400µL/min). 
Larger nanoplates were synthesized by diluting seed solution prior to the addition 
of L-ascorbic acid and silver nitrate. Seed solutions were prepared proportionally in smaller 
quantities and then diluted by addition of diH2O to reach 2.1mL. The reaction then 
proceeded as above. Typically, dilutions were used as follows: 1x for nanoplates with 
absorption peaks up to ~550nm, 1/2x for ~550-590nm (1.05mL seed stock, 1.05mL 
diH2O), 1/4x for ~590-630nm, 1/8x for ~630-700nm and 1/12x for NIR nanoplates. 
4.3.2 Characterization of Silver Nanoprisms 
Characterization of the size and morphology of silver prisms was performed using 
TEM. Samples were placed as drops onto 100 mesh formvar/carbon coated copper for 
approximately 1 hour. Samples were blotted dry from the grids with filter paper and 
samples were allowed to dry. Samples were then examined in a JEM 1010 transmission 
electron microscope (JEOL, USA, Inc., Peabody, MA) at an accelerating voltage of 80 Kv. 
Digital images were obtained using the AMT Imaging System (Advanced Microscopy 
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Techniques Corp., Danvers, MA). Optical spectra were determined using a BioTek 
SynergyHT UV-Vis spectrometer. Samples were diluted to an optical density less than 
four, after which 300µL was placed in a single well of a 96 well plate for reading. 
Absorption spectra were then normalized to have an Area-Under-the-Curve (AUC) of 1. 
4.3.3 Nanoprism Stability Calculations 
Changes in absorption spectra of nanoparticle samples were used as an indicator of 
stability in solution. Calculations were performed by first normalizing both initial 
absorption spectra of a nanoplate solution and those obtained after 24 hours by their AUC 
to obtain area-weighted spectra. Relative error was then calculated as the disagreement 
between the two spectra expressed as a percentage of the agreement according to the 
following formula: 
Instability = 𝐼𝑖𝑛𝑖𝑡⨁𝐼24ℎ/𝐼𝑖𝑛𝑖𝑡 ∩ 𝐼24ℎ 
From the nanoplate spectra, this was calculated using the following equation:  
 
𝐼𝑛𝑠𝑡𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
2(∑(𝐼𝑖𝑛𝑖𝑡
𝑛 − 𝐼24ℎ
𝑛 ))
(2 − ∑(𝐼𝑖𝑛𝑖𝑡
𝑛 − 𝐼24ℎ
𝑛 ))⁄  
Ideal stability (i.e. no change in the absorption spectrum) would result in a 0 under 
this calculation. Anything below 0.15 can be considered to be stable due to noise in spectral 
measurements. 
4.3.4 Nanoprism Adhesion to Glass Substrates 
 Two techniques were used for nanoprism adhesion to glass, which were 
subsequently compared to determine which was preferable for usage in the completed 
device. First, a solution of 2% (3-mercaptopropyl)trimethoxysilane, 5% diH2O in 2-
propanol was prepared. Standard glass slides were treated with 0.05M Sodium Hydroxide 
for 30m at 80C and then washed with diH2O. 50µL droplets of the MPTMS solution were 
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placed on the surface of the slides and placed in an oven heated to 90C for two hours, which 
evaporated the MPTMS solution and allowed for an even surface coating. The slides were 
then removed from the oven and washed in diH2O before being left in the nanoprism 
solution overnight.  
 In the second technique, glass cover slips were placed in a solution of 0.1% poly-
L-lysine for 30 minutes, after which they were removed and dried under a jet of nitrogen. 
The PLL coated slides were then placed in the nanoprism solution for one hour. The optical 
density of the nanoprism solution used varied, but was always held above 3. 
For both methods, after the nanoprism incubation, the slides with nanoprism 
monolayers were removed, washed in diH2O and placed in a separate diH2O bath to prevent 
drying. When ready to be used, the nanoprism coated cover slips were removed from the 
deionized water bath and dried under a jet of nitrogen prior to functionalization. 
4.3.5 Silver Nanoprism Functionalization 
Thiol-linked probes targeted to the DXS gene were obtained from Sigma Aldrich, 5’-[Thi-
C6]ATCGCTGAACGCTACGCTGGTCGATAT. A droplet containing DNA probes 
(35µM) was incubated on the detection zone of a nanoprism coated coverslip for one hour. 
The coverslip was then washed with diH2O and dried under a nitrogen jet. The probe 
concentration was chosen as the minimal concentration required to maximize shift in the 
absorption spectra of the nanoprisms. 
4.3.6 Hyperspectral Imaging 
 Hyperspectral imaging of silver nanoprism monolayers was accomplished using a 
Leica DM6000M microscope and PARISS control software (LightForm, Asheville, NC). 
The microscope was set to brightfield transmitted light using a halogen lamp and 20x 
objective. PARISS control software was used to control stage movement and image 
acquisition. Prior to taking hyperspectral measurements, a lamp spectrum was recorded by 
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placing an uncoated glass slide on the microscope stage, appropriately setting integration 
time and taking 10 acquisitions of a single slice. Once the lamp spectrum was acquired, the 
nanoparticle coated slide was placed on the stage and the integration time was set as before. 
The hyperspectral image was then taken using 100 acquisitions with 5 averages. 
 After image acquisition, resulting data were analyzed in MatLab using custom 
functions. Lamp spectra were used to normalize sample spectra to obtain 2D maps of 
absorption spectra. These maps were then averaged to obtain the average absorption spectra 
of nanoplates in the imaging area between 450 and 800nm. 
4.3.7 LSPRi Optical Assembly 
A custom optical system was developed to image the nanoprism monolayer 
detection zone of the microfluidic chip and measure nanoplate spectral changes over time 
correlating to shift in the local dielectric constant. White light was supplied using a CREE 
XP-G2 5W Warm White LED (RapidLED, Burlingame, CA). Light from the LED was 
collimated through a narrow slit onto a diffraction grating (600 grooves/mm). The 
diffracted light was then incident onto a DLP3000 608x684 pixel digital micromirror 
device (DMD) (Texas Instruments, Dallas, TX) creating a spatial resolution of 
wavelengths. The DMD was used to reflect specific frequency bands onto an optical fiber, 
after which it was collimated into a 3.3mm diameter beam passing through the nanoprism-
coated detection zone of the PCR chip and incident onto a Hamamatsu C2400 CCD camera 
with images collected by frame grabber at 29.97 frames per second. Later experiments 
replaced the Hamamatsu CCD with a Reitiga EXi camera (QICam) with 250ms integration 
time. 
4.3.8 2D Spectroscopic Imaging Analysis 
An initial spectral sweep was performed from 550-650nm and recorded. This was 
used as the baseline data set for determining optical shift. During imaging, this spectral 
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range was repeatedly swept using the optical assembly. The image taken at each 
wavelength was normalized on a pixel-by-pixel basis by the spectral output of the LED at 
that wavelength and then subtracted from the matching image from the baseline sweep to 
create a difference map. The difference maps were then summed across the entire spectrum 
to obtain an integrated difference map which was then displayed using false color. 
4.4 RESULTS 
4.4.1 Selection of Nanoprism Synthesis Regime 
 Following the selection of silver nanoprisms as the ideal form of nanoparticle for 
use in an in-vitro LSPR based biosensor, it was necessary to develop a reproducible 
synthesis for monodisperse, stable nanoprisms. Particles with an absorption peak around 
600nm were ideal to take advantage of optical detection utilizing visible light by a simple 
CCD for minimal detector cost while maximizing spectral shift under a changing local 
dielectric field. In order to determine an appropriate starting point for nanoprism synthesis, 
a number of representative synthesis techniques were utilized to prepare particles, which 
were then compared for monodispersity and functionalizability. 
Representative techniques for photo-induced synthesis[288, 329], hydrogen 
peroxide  mediated seeded growth[300, 330], starch-stabilized seeded growth[331] and 
ascorbic acid mediated seeded growth[301] were utilized to synthesize silver nanoplates. 
Figure 4.1 shows absorption spectra acquired from each synthesis technique. As 
demonstrated, photo-induced, starch-stabilized and one citrate-stabilized seeded growth 
technique resulted in relatively monodisperse nanoprisms. No solvo-thermal methods were 
tested, as they require significantly more complex reaction chemistries and precise control 
of high temperature/pressure systems. Poly-vinyl pirrolidine stabilized synthesis was 
similarly avoided for suspected issues with bioconjugation[330]. 
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Figure 4.1. Representative optical extinction spectra for various silver nanoprism synthesis 
techniques, all spectra normalized to an area-under-the-curve (AUC) of 1. Photoinduced techniques 
include Jin, et al and Xue, et al. Solvothermal techniques include Aherne, et al. Seeded growth 
techniques include Zhang, et al and Li, et al. Parnklang, et al utilizes soluble starch as a stabilizer 
for peroxide etchant growth. 
 
 In order to assess the ability of the nanoparticles from each of these syntheses to be 
functionalized, a simple click-chemistry experiment was utilized to qualitatively measure 
both thiol binding and surface adhesion to a glass substrate. In short, glass slides were 
incubated for 30 min in a 0.01% solution of Poly-L-Lysine and then dried under a jet of 
nitrogen. The coated slides were then incubated for one hour in colloidal nanoprism 
solutions from each of the preparations diluted to an OD of 3, after which they were washed 
and dried under a jet of nitrogen. Silver nanoprisms with a maintained affinity for thiol 
binding would form bonds with the –SH groups on cysteine in the Poly-L-Lysine 
physisorbed to the glass substrate, resulting in a visible monolayer of nanoprisms. As 
shown in Figure 4.2, only the citrate-stabilized seeded growth method resulted in a visible 
monolayer, and thus functional nanoplates. 
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Figure 4.2. Poly-L-Lysine modified glass slides incubated for 30 minutes in OD 3 colloidal 
nanoprism solutions prepared using starch stabilized, seeded growth and photoinduced synthesis 
techniques. No monolayer was formed from starch-stabilized nanoprisms. Photoinduced 
nanoprisms demonstrated adhesion, but to a lesser degree than citrate-stabilized seeded growth. 
 
 The citrate-stabilized, hydrogen peroxide mediated seeded growth method for 
silver nanoplate synthesis carried the additional benefit of easily tunable absorption peaks 
dependent on the quantity of silver ions added during the growth phase. However, as shown 
in Figure 4.3, the synthesis was found to lack reproducibility and stability. 
 
 
Figure 4.3. A) Optical extinction spectra, normalized to an AUC of 1, of repeated preparations of 
silver nanoprisms using the seeded growth protocol found in Li, et al. While absorbance peaks were 
similar in all preparations, the results were inconsistent. B) Change in absorbance spectra after 24 
hours for nanoprisms prepared using the seeded growth technique. 
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4.4.2 Optimization of Silver Nanoprism Synthesis 
To address the lack of stability and the reproducibility of the citrate-stabilized 
nanoprism synthesis, a thorough investigation of the technique was performed examining 
all reagents and synthetic conditions. The two-step synthesis used as a starting point is 
commonly used in peroxide-etchant based techniques where a seed stock is first prepared 
using silver nitrate (AgNO3), hydrogen peroxide (H2O2), trisodium citrate (TSC) and 
sodium borohydride (NaBH4) as a reducing agent. The seeds are aged overnight, diluted in 
diH2O followed by addition of L-ascorbic acid (AA) prior to prism growth with dropwise 
addition of AgNO3. In order to determine the contributions of each reagent, they were 
assayed individually while all other parameters were held constant at the values shown in 
Fig. 4.4. 
 
 
Figure 4.4. Reaction schematic of optimized citrate-stabilized nanoprism synthesis using hydrogen 
peroxide etching. All listed reaction components were evaluated here, those found to have 
significant effects on nanoprism stability and reproducibility are highlighted in bold. 
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 First, L-ascorbic acid (AA) was evaluated - the reducing agent used in the growth 
stage of the prisms. It has been reported that the presence of hydrogen peroxide prevents 
NaBH4 from interfering with prism growth, eliminating the need for overnight aging.[10a] 
Therefore, we evaluated synthesis with fresh and aged-overnight seed solutions. As shown 
in Figs. 4.5A and 4.5B, AA concentration above ~0.1mM was required for prism growth 
to occur, but relatively minute spectral changes were observed above this concentration. 
However, after 24 hours, samples with high AA concentration (>6mM) demonstrated 
significant change in UV-Vis spectrum shape that was especially pronounced in the case 
of fresh seeds (Fig. 4.5C), indicating a lack of stability. This spectral change was quantified 
using the formula Instability = 𝐼𝑖𝑛𝑖𝑡⨁𝐼24ℎ/𝐼𝑖𝑛𝑖𝑡 ∩ 𝐼24ℎ where the disagreement (⊗) 
between initial (Iinit) and 24h (I24h) spectra was divided by their agreement (∩); this measure 
was used as an indicator of stability throughout our study (details in Supporting 
Information). Scores below 0.15 were considered stable because they correlated with small 
spectral changes as shown in examples in Fig 4.5 (C and D, blue spectra). AA 
concentrations ranging from 0.435 to 1.74 mM resulted in the most stable nanoprisms, with 
optimal results at 0.435 mM. As shown in Fig. 4.5E, stability at high AA concentrations 
was markedly increased in samples prepared using aged seeds, though this effect proved 
negligible with reduced AA concentrations. These results show that the secondary reducing 
agent is required for nanoplate synthesis, but its excess reduces stability of nanoparticles. 
This effect is likely associated with nanoparticle degradation in solution due to excess of 
the reducing agent. Further experiments in this study were performed using aged seeds as 
they demonstrated overall better stability in a broad range of AA concentrations.  
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Figure 4.5. (A) Spectra demonstrating effects of varying ascorbic acid during nanoprism synthesis 
with fresh seed solution. (B) Spectra demonstrating effects of varying ascorbic acid during 
nanoprism synthesis with aged seed solution. (C) Representative examples of unstable and stable 
nanoprisms prepared using fresh seeds with 8.7mM (black curves) and 1.74mM (blue curves) 
ascorbic acid concentration, respectively. (D) Examples of spectral changes 24h after nanoprism 
synthesis using aged seeds. (E) Twenty-four hour stability test for nanoprisms prepared using 
various concentrations of ascorbic acid with either aged or fresh seeds; note high level of stability 
for AA concentrations ranging from 0.435 to 1.74 mM.  
 
Next, we studied the effects of hydrogen peroxide, which functions as an etchant, 
and sodium borohydride - the reducing agent responsible for initial seed production, on 
prism synthesis and stability. Nanoprisms with the smallest secondary peak at 400nm 
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resulted from seed stock with [H2O2] between 88 and 121 µM (Fig. 4.6A). Neither H2O2 
nor NaBH4 demonstrated any impact on prism stability. (Figs. 4.6B and D). 
 
 
Figure 4.6. A) and B) Effect of hydrogen peroxide on nanoprism spectra (A) and stability (B). 
Ideal nanoprism growth (sharper peaks and reduced 400nm secondary peak) was found to occur 
with H2O2 concentrations ranging from 88 - 121µM in the seed stock preparation. No effect on 
stability was observed. C) and D) Effect of sodium borohydride on absorption spectra (C) and 
stability of nanoprisms (D). NaBH4 concentrations above ~250 µM were required for ideal 
nanoprism growth. No effect on stability was observed. 
 
 
 
 80 
 
Figure 4.7. (A) Absorbance spectra demonstrating effects of seed dilution on nanoprism growth 
with seed concentrations 1x, 0.5x, 0.2x, 0.1x and 0.05x of the initially prepared seed stock. All 
experiments were performed with dropwise addition of 100µL of silver nitrate. (B) Twenty-four 
hour change in spectral shape for varying concentrations of ascorbic acid in nanoprisms prepared 
from 0.1x seed solution. 
 
 
It was observed that during the prism growth stage, further addition of silver nitrate 
beyond one-tenth of the initial reaction volume did not result in further growth, preventing 
synthesis of larger prisms. In order to address this limitation, the effect of seed 
concentration was evaluated in the context of increasing nanoprism size. As shown in Fig. 
4.7A, reducing seed stock concentration resulted in synthesis of larger nanoprisms with 
absorbance peaks up to 900 nm, due to fewer seed particles incorporating the same quantity 
of silver nitrate. Optimal stability occurred at 0.435mM AA (Fig. 4.7B), indicating that 
ideal AA concentration was not variant with seed concentration. Figure 4.8 shows how 
silver nanoprism size varies with silver nitrate addition under different dilution conditions. 
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Figure 4.8. Absorption peak of silver nanoprisms by volume of silver nitrate added, grown from 
different dilutions of seed stock. All data points gathered using 10.5mL initial solution. Increased 
levels of dilution allow for growth of larger nanoplates with the same quantity of silver nitrate 
added. 
 
 Next, we analyzed the effects of trisodium citrate - a capping agent and stabilizer 
(Fig. 4.9). For small prism sizes with less than ~35 nm edge length, varying the trisodium 
citrate concentration resulted in little difference in UV-Vis spectra (Fig. 4.9A). For larger 
prisms, the peaks broadened significantly at lower concentrations of sodium citrate (Fig. 
4.9B). Sodium citrate is known to act as a surface stabilization element, binding to the 
facets and preventing the addition of silver ions thus halting nanoparticle growth [7a]. 
Therefore, we hypothesized that higher concentrations of sodium citrate are required to 
achieve consistent synthesis of larger nanoprisms.  
 
 
 82 
 
Figure 4.9. (A) Absorbance spectra of small nanoprisms (~30nm edge length) prepared from aged 
seed solution with varied concentration of tri-sodium citrate (TSC). Reactions proceed more rapidly 
with lower TSC concentration, but optical properties remain similar. (B) Spectra of larger 
nanoprisms (~100nm edge length) prepared from seed solution with varied concentration of sodium 
citrate. Note a significant widening of plasmonic peaks at lower citrate concentrations. (C) Scatter 
plot of full-width at half-maximum (FWHM) as a function of nanoprism absorption peak 
wavelength for varied concentrations of sodium citrate; note a relative increase in FWHM for larger 
nanoprisms at lower concentrations of sodium citrate. 
 
 
To verify this, nanoprisms were synthesized with concentrations of sodium citrate 
ranging from 0.71 to 5.36mM. For each concentration, nanoparticles were grown to various 
sizes by changing the quantity of silver nitrate added, with absorbance peaks ranging from 
450nm to 780nm. Then peak full-width at half-maximum (FWHM) was used as an 
indicator of nanoprism dispersity (Fig. 4.9C). The narrowest FWHM of ~80nm occurred 
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for smaller nanoplates (~20nm edge length) for all concentration of sodium citrate. 
However, FWHM increased faster with prism size for lower sodium citrate concentrations, 
indicating higher variation in particle morphologies.  
 Finally, the effect of rate of silver nitrate addition during prism growth was 
analyzed. Silver nitrate was added continuously to seed stock solution using an automated 
syringe pump at flow rates ranging from 15 – 400µL/min. Three seed stock formulations 
were used – 3.57mM TSC (base reaction condition, Fig. 4.4), 0.71mM TSC (reduced 
citrate) and ½ seed stock concentration (reduced concentration for larger prism growth). 
Slower rate of silver nitrate addition was better under all reaction conditions tested; this 
was evident from a reduced secondary peak at 400nm and red-shifted spectra indicating 
increased silver incorporation, and thus larger prisms, as well as better control of nanoplate 
morphology (Fig. 4.10). Little improvement in nanoprism quality was observed below the 
speed of ca. 50 µL/min at all conditions tested. We found that flow rate had very little 
effect on the stability of prisms, as Instability values were consistently below 0.15. (Fig. 
4.10D). 
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Figure 4.10. Absorbance spectra demonstrating effects of varying rate of silver nitrate addition in 
the case of: (A) 3.57mM TSC seed solution; (B) 3.57mM TSC seed solution diluted 1:1 with diH2O 
prior to prism growth; and  (C) 0.71mM TSC seed solution. (D) Relative spectral changes after 24h 
storage demonstrating stability of nanoprisms at reaction conditions tested.  
 
 
Using the optimized parameters from our experiments, we developed a finalized 
protocol for synthesis of stable silver nanoprisms in a wide range of sizes (Fig. 4.11). The 
nanoprisms exhibit plasmon resonance peaks covering the whole visible and near-infrared 
(NIR) spectral region (Fig. 4.14, A-B).  
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Figure 4.11. (A) Representative TEM image of silver nanoplates prepared using the synthesis 
presented here. Morphology of the prisms is consistent with those reported in literature. (B) TEM 
showing stacked nanoplates; the plate thickness is ca. 7 nm. (C-F) Representative TEM images 
showing nanoplates with sizes 105nm (C), 40nm (D), 45nm (E), 50nm (F) 
 
 
 Pursuant to our results that nanoplates synthesized from fresh seeds are stable in 
reactions with low ascorbic acid concentrations, we demonstrated a one-pot variant of the 
optimized protocol described here for synthesis of stable nanoplates (Fig. 4.12). In this 
variant, seed solution is prepared as previously described, however, it is then utilized for 
prism growth without aging. Additionally, we found that the protocol is fully scalable in 
synthesis volumes ranging from 2.3 to 46 mL prior to addition of silver nitrate (Fig. 4.13). 
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Figure 4.12. Demonstration of one-pot synthesis of silver nanoprisms using freshly prepared seed 
solution and low ascorbic acid concentration (0.435mM). At this concentration of ascorbic acid, 
fresh seed stock showed no loss in stability compared to aged seed stock, allowing for one-pot 
synthesis. 
 
 
Figure 4.13. Comparative absorption spectra of nanoplates using larger synthesis volume. No 
differences were observed between nanoplate solutions using low volume and high volume 
syntheses. Volumes larger than 48mL were not tested. 
 
4.4.3 Functionalization and Adhesion of Nanoprisms 
In order to verify that the prisms prepared using this protocol can be used for a 
simple surface functionalization using thiol chemistry, we attached the nanoprisms to a 
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glass slide coated with (3-mercaptopropyl)trimethoxysilane (MPTMS) (Fig. 4.14C). The 
nanoprisms formed a uniform dense layer on the thiol-modified glass slide while none 
adhered to untreated slides. 
 
 
 
 
Figure 4.14. (A) Absorption spectra, normalized to a peak absorbance of one, for a subset of 
nanoprism sizes obtained. (B) Nanoprism suspensions in water demonstrating the range of 
achievable particle colors.  (C) Slide coated with ~50nm edge length nanoprisms using thiol 
modification of the glass surface.  
 While (3-mercaptopropyl)trimethoxysilane treatment has long been used as a 
standard for thiol-coating of glass substrates for binding to silver or gold 
nanoparticles[274], the requirement for careful hydroxylation and silanization prior to 
adhesion of nanoparticles resulted in a far more complex process than the usage of simple 
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physisorption of poly-L-lysine, which resulted in similarly consistent nanoparticle 
monolayers. MPTMS-mediated thiol modification of glass substrates proved to be 
unreliable compared to PLL, the increased complexity of the reaction resulted in failed 
monolayers with no adhesion far more often, while PLL proved strongly reliable and did 
not interfere with probe binding. It was decided to further assay PLL-mediated monolayers 
to verify they could be used for the LSPR chip.  
 In order to be usable in the LSPR chip, the nanoprism monolayer needed to be 
stable under all conditions that the chip would operate under. As shown in Figure 4.15, 
PLL mediated monolayers maintained integrity under one hour of piezoelectric pumping 
using the same conditions as would be used in the PCR chip (Fig. 4.15B), as well as heating 
to 95C for 30 minutes in a microchannel filled with deionized water (Fig.4.15A). As a 
result of these experiments, PLL was used to immobilize nanoprisms on glass substrates 
for all further experiments. 
 
 
Figure 4.15. A) Heating stability test. Hyperspectral results showing comparative spectra before 
and after heating at 95C for 30 minutes in a flow channel. B) Hyperspectral results showing 
comparative spectra before and after one hour under piezoelectric pumping at 70V and 110Hz. 
Neither showed any significant spectra changes, indicating stability under PCR reaction conditions. 
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4.4.4 Development of Optical LSPRi System 
 In order to perform LSPR imaging in a microfluidic system, it was necessary to 
construct an optical system capable of detecting small changes in the absorption spectra of 
the nanoprisms making up the array. In order to allow for point-of-care diagnostics, this 
optical system needed to be self-contained, with a relatively small footprint and low power 
requirements and the ability to take a 2D image. To this end, an optical system based on 
the use of diffraction and a digital micromirror device (DMD) to fraction out the light into 
spectral components was utilized in lieu of a dedicated spectrophotometer. The operating 
principle of the imaging system was to take white light, collimate it through a diffraction 
grating to break it down into spectral components, focus the separated spectrum onto a 
DMD, which could then be used to isolate frequency bands and pass them on to an optical 
fiber, which would collect the output light into a collimator to create a beam incident on 
the detection zone and into a CCD camera. Figure 4.16 shows a diagram of the optical 
pathway.  
 
 
Figure 4.16. Planned optical pathway for localized surface plasmon resonance imaging utilizing a 
digital micromirror device to separate diffracted light for spectral resolution. 
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 The primary components involved in the optimization of luminous flux and spectra 
resolution for the optical system consisted of the light source, diffraction method, 
frequency selection at the DMD, and the optical fiber output and collimation. For 
illumination, white light sources commonly used in microscopy, halogen, xenon and LED 
sources, were considered. Figure 4.17 shows representative spectral output of each of these 
options.  
 
 
 
Figure 4.17. Typical spectral output of A) halogen lamp (image credit to Zeiss), B) xenon lamp 
(image credit to Zeiss), C) CREE XP-G2 warm white LED (image credit to RapidLED) 
 
All three provide strong illumination in the 550-700nm range that was ideal for 
measuring spectral shifts in nanoprisms with a 600nm absorption peak. Halogen and xenon 
lamps also showed a significant contribution in the near-infrared spectrum, which can 
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result in significant heat generation in the optical pathway. With a long imaging time and 
a system already under heating from PCR, extra heat input could prove problematic, so 
LED illumination was chosen to avoid these heating effects. The CREE XP-G2 warm white 
LED (RapidLED, Burlingame, CA) was selected for its ideal spectral output (Fig. 4.17C) 
and high optical flux. 
 The diffraction system and frequency separation at the DMD were the primary 
sources of both spectral resolution and loss of optical flux, meaning that these needed to 
be carefully balanced to achieve maximal resolution without losing signal. Due to the fact 
that spectral resolution depended on spatial resolution of the diffracted light incident on the 
DMD, only a portion of the visible spectrum (from approximately 550-680nm) was focused 
onto the DMD in order to maximize resolution in the region around the absorption peak of 
the nanoparticles. To verify the selected spectral range, a glass cover slip was coated with 
a monolayer of nanoprisms with a 600nm absorption peak and placed in the path of 
spatially separated light reflected from the DMD (Fig. 4.18). A CCD camera (Hamamatsu) 
was used to collect the light transmitted through the nanoparticle monolayer. The 
transmitted light spectra were converted to absorption spectra by normalizing by 
measurements taken through a clean glass cover slip. As shown in Figure 4.18C, the 
resultant spectrum matched to the expected spectrum from colloidal UV-Vis measurements 
as well as hyperspectral measurements taken of the same cover slip. The hyperspectral 
measurements were used to match the exact spectral range measured by the optical system, 
resulting in a range of 450-650nm. 
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Figure 4.18. A) Normalized transmitted spectrum as measured from spatially resolved spectral 
illumination through a clean glass coverslip. B) Normalized transmittance through a glass coverslip 
coated with a monolayer of nanoprisms with a 600nm absorbance peak. C) Transmittance through 
nanoprism monolayer normalized by the measured spectral transmittance through the blank slide. 
Note that the spectrum matches well to D) Transmittance of colloidal nanoprisms from 450-650nm 
with an absorbance peak at 600nm as measured using UV-Vis spectroscopy. 
 
 In order to improve spectral resolution, the imaging band was narrowed, after 
which, to further characterize and optimize the spectral resolution of the detection system, 
images were taken of the spectra resulting from passing the diffracted light through a series 
of bandpass filters with known spectral throughput – XF3084535AF45 (535nm center, 
45nm FWHM), XF1021550DF30 (550nm center, 30nm FWHM), XF1045560DF15 
(560nm center, 15nm FWHM), QMAX/EX620-650/25 (620-650nm band), and 
XF3059QBEM90168 (580-615nm band) (Horiba, Alvin, TX).The obtained images were 
then correlated to the known spectral bands to determine edge locations and compared to 
 93 
the calculated edge location assuming perfect spectral resolution. As shown in Figure 
4.19A, there was a significant mismatch observed. To reduce this effect, the width of the 
slit was reduced to 0.5mm and 0.3mm and the same experiment performed. Figure 4.19A 
also shows the resulting spectral resolution values. Below 0.3mm, the optical flux of the 
system was deemed too low for effective measurements, so the slit was set to 0.3mm for 
the remainder of experiments (Fig 4.19B). 
 
 
Figure 4.19. A) Spatially separated transmission through a 620-650nm bandpass filter using 1mm, 
0.5mm and 0.3mm aperture sizes prior to the diffraction grating as compared to actual transmission 
through the filter. The 0.3mm aperture had a full-width half-maximum from 615-652nm, very close 
to the theoretical 620-650nm. B) Spatially separated transmission through a series of bandpass 
filters with a 0.3mm aperture prior to the diffraction grating. Using these values, the spatial 
separation on the DMD was matched to spectral output, giving a range of 540 to 680nm. 
 
4.4.5 Verification of Optical LSPR Imaging 
 Once the LSPR optical detection system was finalized, the system was verified by 
measuring the absorption spectrum of nanoprism monolayers adhered to glass cover slips. 
Silver nanoprisms with an absorbance peak at 555nm were utilized and adhered to the 
substrate. The cover slip was then measured, along with a blank cover slip, on both the 
LSPR imaging system and hyperspectral. The optical detection system was then used to 
measure spectral shift in a nanoprism monolayer under different conditions. A layer of dry 
film adhesive was applied to the cover slip leaving open quadrants. Droplets of solvents – 
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deionized water (dielectric constant of 88) and glycerol (dielectric constant of 42.5) were 
placed in the quadrants as indicative of likely shift sizes and pressed down with a clean 
glass cover slip. Measurements were then taken using the LSPR imaging system and 
hyperspectral microscopy. The LSPR imaging measurements, taken using the Reitiga EXi 
camera with 250ms integration time, demonstrated a shift of ~15nm between dry and 
water-coated particles, and ~20nm between water and glycerol coated particles. These 
results agreed with the hyperspectral measurements. For calculations directly from 
measured transmission, avoiding the need for normalization by illumination spectra, an 
average measured shift of 2.6% in measured transmission was observed to correspond to 
the 20nm shift, indicating an upper bound of expected signal during DNA hybridization 
experiments. 
 
 
Figure 4.20. A) Raw transmission collected by Reitiga EXi camera for LSPR imaging of 
blank cover slip, dry nanoprism monolayer (colloidal absorbance peak at 555nm), 
nanoprisms coated in deionized water and nanoprisms coated in glycerol. B) Transmission 
for nanoprism monolayers normalized by light source spectral output as measured through 
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blank cover slip. C) Hyperspectral measurements for dry nanoprism monolayer and 
monolayers coated with deionized water or glycerol. D) Comparison of hyperspectral and 
LSPRi system measurements of dry nanoprism monolayer, water-coated and glycerol-
coated monolayer over the region from 560-640nm. Note strong similarity between curves. 
 
4.5 DISCUSSION 
Noble metal nanoparticle based detection regimes such as SERS and SPR boast 
impressive sensitivity to small changes in local dielectric constant such as those resulting 
from surface binding of biomolecules. They also carry the added benefits of being label-
free and applicable to a wide variety potential assays as long as an appropriate thiol-linked 
probe can be synthesized (DNA hybridization probes, antibodies, etc). In particular, 
localized surface plasmon resonance using nanoprisms with high anisotropy for strong 
shifts in absorption spectrum with dielectric changes leads to potential for colorimetric 
sensors and spatially resolved imaging techniques for multiplex analysis. 
As the sensitivity of an LSPR imaging system is highly dependent on the properties 
of the nanoparticles used to form a monolayer on the detection array substrate, multiple 
silver nanoprism synthesis techniques were assayed for optical properties and 
functionalizability. Further, the various components of citrate-stabilized chemical 
synthesis of silver nanoplates using hydrogen peroxide were systematically tested. Greatly 
increased stability of nanoprisms was demonstrated by controlling ascorbic acid 
concentration, allowing for stable one-pot synthesis. Additionally, tight control of 
nanoprism synthesis was achieved through optimization of seed stock dilution, citrate 
concentration and rate of silver nitrate addition. Using the optimized parameters of the 
reaction, a scalable, refined protocol for growth of silver nanoprisms was developed with 
fully tunable plasmon resonances across the visual spectrum and into the near infrared. 
These particles were shown to be viable for surface functionalization in biosensor 
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applications using thiol chemistry. In addition, nanoprism monolayers were tested for 
viability under the heating and flow conditions in the fluidic system presented in the 
previous chapter. 
An optical imaging system was developed using diffracted white light from and 
LED incident on a digital micromirror device to allow for two-dimensional, time resolved 
spectral imaging and measure shift over time in absorption spectra of nanoparticles 
adsorbed on a glass substrate. This system was optimized for luminous flux and 
characterized, with a final spectral resolution of 2nm measured in 40 points across the range 
from 560-640nm. The resulting LSPR imaging system was utilized to measure spectra of 
nanoprisms under multiple solvent conditions to determine expected levels of optical shift 
for DNA hybridization. A shift of approximately 20nm was observed between water 
(dielectric constant of 88) and glycerol (dielectric constant of 42.5), similar to that expected 
between prisms functionalized with probes and DNA hybridization. For detection 
purposes, this resulted in a measurable direct shift in transmission of ~2.6%, which can be 
considered the upper end of expected signal. 
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CHAPTER 5: 
Microfluidic PCR with On-Chip LSPRi for Rapid Characterization of 
Bacterial Genetic Markers 
5.1 ABSTRACT 
 The results from the previous two chapters were aimed at developing a rapid 
platform for thermocycling and an optical localized surface plasmon resonance system, 
respectively. While each of these systems has novelties that makes them unique, separate 
neither has potential for overcoming a challenge such as detection and characterization of 
microbial pathogens or any other rare cells. However, each method was designed to 
complement the other – recirculating PCR provides advantages to DNA hybridization 
detection, as discussed in Chapter 3, and LSPR imaging is a highly sensitive platform 
capable of both label-free and multiplex detection well suited to targeting DNA. 
 In this chapter, the two systems have been integrated and validated for successful 
amplification of DNA using both fluorescent measurements on gel electrophoresis and 
LSPR detection of optical shift. The limit of detection was observed to be ~5fg/µL of input 
E. coli DNA, or approximately 59 bacteria in a 200µL sample. While this concentration 
was too low to achieve signal saturation, an observable increase above baseline noise was 
present. Signal saturation occurred at DNA inputs of 50fg/µL and higher, resulting in a 
saturated signal of 1% shift. This shift was lower than anticipated, but the sensitivity of the 
LSPR imaging system was capable of resolving the difference. Further, multiplex PCR 
amplification and detection was demonstrated using isolates of E. coli tufB and DXS gene 
targets. Detection of DNA hybridization was consistently achieved within 15 minutes for 
positive samples, or about 20 cycles. This demonstrates strong potential for future work in 
rapid detection of resistance marker panels for bloodstream infections. 
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5.2 INTRODUCTION 
When addressing the problem of rapid characterization of pathogens in bloodstream 
infections, a number of factors must be taken into consideration. While timeliness arises 
first and foremost, sensitivity and specificity must also be addressed – a rapid detection 
scheme that cannot discriminate between targets or detect low sample concentrations 
would not be viable for clinical usage without the time-limiting step of cell culture[165, 
166]. The previous chapters discussed the development of some of these elements – rapid 
thermocycling for amplification of potentially multiplexed target genes, and highly 
sensitive localized surface plasmon resonance detection using low-cost optical 
components, neither address the ultimate problem of combined sensitivity and specificity 
on their own. As a result, it is necessary to consider the whole device and demonstrate 
functionality of LSPR imaging in the changing environment of a thermocycler, and verify 
both limit of detection and the ability to discriminate targets for theoretical analysis for a 
panel of markers. 
As a culmination of the work presented in the previous chapters, this chapter 
describes the implementation of LSPR imaging into a microfluidic thermocycler for real-
time detection of target DNA sequences following PCR amplification. The fully 
constructed LSPR/thermocycling chip was verified using fluorescent detection of 
amplicons on agarose gel to ensure successful PCR amplification. The sensitivity of the 
optical system to shifts in extinction spectra following DNA hybridization was analyzed 
and custom software was developed to maximize detection in a short time frame. In 
addition, the limit of detection of the completed system was measured using a 
concentration series of input DNA from E.coli, and potential for multiplexed analysis of 
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genetic target was determined with side-by-side detection of tufB[332] and DXS[333] gene 
targets. 
5.3 MATERIALS AND METHODS 
5.3.1 Nanoprism Synthesis 
Nanoprisms were prepared using a modified form of a citrate-stabilized, hydrogen 
peroxide etchant based seeded growth technique. In brief, a solution was prepared 
consisting of 16.97mL diH2O, 1mL Trisodium Citrate (75mM), 93µL Silver Nitrate 
(10mM) and 128µL Hydrogen Peroxide (0.5%). 96µL Sodium Borohydride (100mM) was 
added under vigorous stirring until the solution turned golden yellow. The solution was 
allowed to age overnight prior to addition of 21mL diH2O and 2mL L-Ascorbic Acid 
(10mM). Approximately 1mL of Silver Nitrate (10mM) was then added dropwise at a flow 
rate of 100µL/min until the solution reached an absorption peak at 580nm as observed 
using a UV-Vis spectrometer. 
5.3.2 Nanoprism Adhesion to Glass Substrates 
Glass cover slips were coated in nanoprisms using a two-step process. First, 24x40mm 
borosilicate glass cover slips were cleaned using aqua regia and washed carefully with 
diH2O prior to incubation in a solution of 0.01% Poly-L-Lysine (PLL) for 10 minutes. The 
PLL physisorbed to the glass substrate, creating a thiol-modified surface. The cover slips 
were then blown dry under a jet of nitrogen, rinsed in diH2O and allowed to incubate for 
20 minutes in a colloidal nanoprism solution with an OD >3. Following this incubation 
period, the cover slips were removed from the nanoparticle solution, rinsed in diH2O and 
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dried under a jet of nitrogen. This technique resulted in reliable formation of consistent 
nanoprism monolayers for particles of all sizes. Two nanoprism sizes were used in 
experiments in this chapter - ~50nm edge length particles with an absorbance peak at 
600nm, and ~45nm edge length particles with an absorbance peak at 555nm. 
5.3.3 DNA Probe Bioconjugation 
Thiol-linked probes targeted to the DXS and tufB genes for Escherichia coli were obtained 
from Sigma Aldrich, (tufB: 5’-[Thi-C6]CGTGCGATTGACAAGCCGTTCC, DXS: 5’-
[Thi-C6]ATCGCTGAACGCTACGCTGGTCGATAT). A 10µL droplet containing DNA 
probes in diH2O (35µM) was incubated on the detection zone of a nanoprism coated 
coverslip for one hour. The coverslip was then washed with diH2O and dried under a 
nitrogen jet. The chosen probe concentration was utilized as the minimal concentration 
required to maximize shift in the absorption spectra of the nanoprism, as determined by 
experiments that will be described in more detail below. 
5.3.4 Fabrication of PCR Chip 
Figure 5.1A shows the design scheme for the microfluidic chip. 200µm deep channel 
structures were milled out from Makrolon polycarbonate and ramped to no depth in a 
4x5mm detection zone (Fig. 5.1B). Prior to use in PCR experiments, the polycarbonate 
chip was filled with 1mg/mL bovine serum albumin (BSA) and allowed to incubate for 30 
min prior to the removal of the BSA and dried using a jet of nitrogen to create a passivation 
monolayer and improve wetting. The polycarbonate chip was then adhered to a nanoprism 
coated glass coverslip for the detection zone and 36-gauge aluminium for the heating zone 
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using 100µm layer of dry film adhesive (3M). The boundary between the two materials 
was sealed using dry film adhesive, followed by a small piece of cut borosilicate glass to 
prevent deformation under heating. A piezoelectric buzzer and PEEK tubing for input and 
output were also bonded to the chip. All gaps were then sealed using NOA68 UV-cured 
adhesive (ThorLabs).  
 
Figure 5.1. A) Layout and construction of combined LSPRi/Recirculating PCR chip (top), cross-
section of materials used (bottom). B) Image of milled polycarbonate substrate with piezoelectric 
buzzer and inlets/outlets in place. 
 
5.3.5 Piezoelectric Pumping 
Piezoelectric pumping was accomplished using a signal generator (BioRad), 10x voltage 
amplifier and piezoelectric buzzer (Digikey). The piezoelectric buzzer was coated with a 
100µm layer of dry film adhesive followed by a 16µm layer of aluminium to prevent 
inhibition of PCR by leaching of copper ions. The buzzer was then sealed into the milled 
polycarbonate chip as described above. The signal generator was set to 4V at 110 Hz and 
connected to the amplifier to achieve a pumping rate of 40µL/m. The output of the 
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amplifier was connected directly to the piezoelectric buzzer leads. Optimal parameters for 
pumping were determined by measuring effective flow rate under a range of voltage and 
frequency conditions as described in Chapter 3. 
5.3.6 Thermocycling Control 
Heating was provided using a Thermoelectric Cooler (TEC). Power was supplied using a 
24V, 4A power supply (BioTec NG 60-5). Temperature control was managed using a 
resistance thermal detector (RTD, Digikey) connected via wheatstone bridge assembly to 
an Arduino Uno microcontroller running a custom PID control program. Circuit diagram 
and PID program control code can be found in the appendices. 
5.3.7 LSPRi Optical Assembly 
Localized surface plasmon imaging of hybridization detection zone was achieved using the 
optical system described in Chapter 4. White light was supplied using a CREE XP-G2 
Warm White LED (RapidLED). Light from the LED was collimated through a narrow slit 
onto a diffraction grating with 600 grooves/mm (ThorLabs). The diffracted light was then 
incident onto a DLP3000 608x684 pixel digital micromirror device (DMD, Texas 
Instruments) creating a spatial resolution of wavelengths. The DMD was used to reflect 
specific frequency bands onto a 1mm diameter multimode optical fiber (ThorLabs), after 
which it was collimated into a 3.3mm diameter beam passing through the nanoprism-coated 
detection zone of the PCR chip and incident onto a CCD camera. Two camera systems 
were used for experiments in this chapter: a Hamamatsu C2400 CCD, and a Reitiga EXi 
(QICam). For the Hamamatsu CCD, frame grabber software was used to collect images at 
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30 frames per second, followed by analysis in MatLab. For the Reitiga EXi, integration 
time was set to 250ms and images were collected through QCapture Pro 7 software. 
Collected images were then converted to .avi video files for subsequent analysis in MatLab. 
5.3.8 LSPR Imaging Data Analysis 
Two image analysis techniques were utilized in the experiments in this chapter. In both 
cases, images were collected at each multiple wavelength points as defined by spatial 
separation on the DMD. Prior to running PCR, a single spectral sweep was performed from 
560-640nm to generate an initial spectrum. Following this, spectra were measured over 
time during thermocycling. For the first analysis technique, images taken at each 
wavelength point were averaged to reduce noise, after which a modified form of the 
‘instability’ calculation demonstrated in Chapter 4 was used to quantitatively measure 
change in spectral shape. In short, time-resolved spectra at each pixel were normalized by 
their sum, after which normalized spectra were compared to the initial spectrum using the 
equation:  
𝑰𝒊,𝒋 =
𝟐∑ |𝑰𝒊,𝒋
𝒐 − 𝑰𝒊,𝒋
𝒄 |𝝀
(𝟐 − ∑ |𝑰𝒊,𝒋
𝒐 − 𝑰𝒊,𝒋
𝒄 |𝝀 )
 
Where Io was the initial spectrum and Ic was the subsequently captured spectrum. This 
created an image map of the change in spectral shape at each pixel. 
 While this technique performs well for full spectra, it proved unable to detect 
changes in spectral shape when only presented with half of a spectrum, as measured when 
scanning 560-640nm with smaller prism sizes. Spectral shifts appearing largely as simple 
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decrease in signal were eliminated during the normalization step. Since scanning the sloped 
region of the spectrum resulted in the best possible resolution, a second analysis technique 
was utilized. In this variant, measured spectra were compared directly, made possible by 
the greatly increased signal-to-noise ratio of the Reitiga EXi camera. At each pixel, the 
difference map value was calculated by 𝑰𝒊,𝒋 =
|𝑰𝒊,𝒋
𝒐 −𝑰𝒊,𝒋
𝒄 |
𝑰𝒊,𝒋
𝒄 . 
5.3.9 Hyperspectral Imaging 
 Hyperspectral imaging of silver nanoprism monolayers was accomplished using a 
Leica DM6000M microscope and PARISS control software. The microscope was set to 
brightfield transmitted light using a halogen lamp and 20x objective. PARISS control 
software was used to control stage movement and image acquisition. Integration time was 
set to maintain intensity between 180-200. Prior to taking hyperspectral measurements, a 
lamp spectrum was recorded by placing an uncoated glass slide on the microscope stage, 
appropriately setting integration time and taking 10 acquisitions of a single slice. Once the 
lamp spectrum was acquired, the nanoparticle coated slide was placed on the stage and the 
integration time was set as before. The hyperspectral image was then taken using 100 
acquisitions with 5 averages. 
 After image acquisition, resulting data were analyzed in MatLab using custom 
functions. Lamp spectra were used to normalize sample spectra to obtain 2D maps of 
absorption spectra. These maps were then averaged to obtain the average absorption spectra 
of nanoplates in the imaging area between 450 and 800nm. 
5.3.10 DNA Isolation Protocol 
DNA solutions were prepared from Stbl3 E.coli (ThermoFisher, Waltham, MA) 
transformed with the pUC19 plasmid (Sigma Aldrich, St. Louis, MO). Bacteria were grown 
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in an incubator at 37C for two days in LB Broth containing 100µM ampicillin prior to 
harvesting and centrifugation. The resulting bacteria were then lysed and DNA was isolated 
using a DNEasy Blood and Tissue Kit (Qiagen, Hilden, Germany). DNA samples were 
then analysed using a NanoDrop (ThermoFisher) to determine concentration and verify 
purity. 
5.3.11 PCR Protocols 
The AmpliTaq Gold PCR protocol (ThermoFisher, Waltham, MA) was utilized for all 
experiments in this chapter. Experimental solutions consisted of 50% v/v AmpliTaq Gold 
PCR Master Mix (ThermoFisher), 10% v/v sense primer (5µM), 10% v/v anti-sense primer 
(5µM) and 30% v/v DNA solution prepared from bacterial lysate to result in final 
concentrations ranging from 5fg/µL to 50pg/µL. All solutions were prepared fresh just 
prior to thermocycling. Primers were used targeting E. coli tufB and DXS genes. A slight 
modification to the AmpliTaq Gold protocol was used to guarantee accuracy during fast 
cycling on the PCR chip: step times were set to 5 seconds at 96C, 6 seconds at 60C and 10 
seconds at 70C. A hot-start period of 4 minutes at 95C was utilized for PCR chip 
experiments. 
5.3.12 Experimental Setup 
In a typical experiment, the PCR chip was loaded with a small amount of mineral oil to 
coat channel edges and heated to 94C for 3 minutes to remove interfacial air bubbles. Then 
200µL of PCR solution was loaded into the PCR chip prior to closing the microvalves. The 
chip was then placed on the TEC thermocycler with a thin layer of thermal paste such that 
the detection zone was in line with the beam from the optical assembly. The optical system 
was allowed to pass through one spectral sweep as described above prior to turning on the 
piezoelectric pumping and thermocycling control. Experiments were allowed to run for 35 
cycles, or approximately 30 minutes. 
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5.4 RESULTS 
5.4.1 DNA Probe Functionalization Kinetics 
In order to maximize signal from a hybridization based LSPR system, it was first 
necessary to determine the ideal concentration of DNA probes to use for functionalization. 
Typically, this is performed by determining the lowest concentration of probes at which 
maximum spectral shift occurs – past an asymptotic point, further addition of probes does 
not result in an appreciable increase in functionalization, and thus spectral shift. To 
determine this, a nanoprism coated cover slip was prepared as previously described, and 
10µL droplets containing probes for the E. coli DXS gene at concentrations ranging from 
7µM to 70µM were placed on the surface and allowed to incubate for one hour. After this, 
the cover slip was washed, dried under a jet of nitrogen, and hyperspectral measurements 
of each functionalized region were taken, along with a reference zone that had been 
incubated with diH2O. Figure 5.2 shows the resulting spectra – a concentration of 35µM 
resulted in the strongest spectral shift, so this concentration was used for all further 
experiments. 
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Figure 5.2. Observed spectral shift using hyperspectral imaging from a dry nanoprism monolayer 
following incubation for one hour with varying concentrations of probes for the DXS target gene. 
35µM probes resulted in the largest spectral shift, and this concentration was used for all future 
experiments. Observed distortion effects in the spectra are likely due to the presence of residue 
dried onto the monolayer surface. 
 
5.4.2 Verification of Combined LSPRi/PCR Chip 
After verification of the LSPR detection system in Chapter 4, a separate validation step 
was performed for the looped PCR system prior to combining elements. A PCR chip was 
constructed and filled as described above with primers targeting the E. coli DXS gene, after 
which it was allowed to thermocycle for 35 cycles. After PCR completion, the sample was 
removed from the chip, incubated for 30 minutes with 1X SYBRgreen dye and loaded on 
a 2% agarose gel for electrophoresis. The resulting bands were then read for fluorescence 
under UV illumination (Fig. 5.3). The presence of fluorescent bands in only the samples 
that had undergone PCR on the chip indicated that it was functional, and no PCR inhibition 
 108 
was caused by the probe-modified silver nanoprisms. The nanoprism layer also remained 
intact, verifying earlier results on stability under thermocycling and pumping conditions. 
 
 
Figure 5.3. Gel electrophoresis results following incubation for 20m with 1x SybrGreen dye for 
output from Recirculating PCR/LSPRi chip. Silver nanoprisms in the detection array were 
functionalized with probes for the E.coli tufB gene rather than the DXS gene targeted for 
amplification to prevent loss of DNA output signal from hybridization. 
 
Following validation of the ability of the fully constructed chip to successfully 
amplify target DNA, the next step was to demonstrate LSPR imaging detection of such an 
amplification. To accomplish this, the PCR chip was prepared as previously described, 
with a nanoprism detection zone functionalized with probes for the E. coli DXS gene. PCR 
reaction mix was prepared for this target gene and loaded into the chip, after which it was 
placed on the TEC thermocycler with detection zone in the path of the output beam and 
allowed to run for 35 cycles under constant measurement. Figure 5.4 shows a diagram of 
the heating cycle time, demonstrating accurate control of temperature across the 
experiment, though some minor oscillation effects were seen in the hot-start step. This was 
likely due to damage to the TEC following an electrical short, which resulted in reduced 
heating potential that the control program did not account for. 
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Figure 5.4. Thermocycling cycle diagram demonstrating measured temperature over time over the 
course of a typical PCR experiment consisting of 35 cycles. Oscillation present in the hot-start step 
is due to change in heating rate parameters resulting from minor damage to the thermoelectric 
cooler unaccounted for in PID calculations. 
 
 Following data collection, images were collated and analyzed in MatLab using 
method 1 as described in the Materials and Methods section. Figure 5.5A shows the 
resulting spectral shift after normalization by the spectral output of the light source – the 
signal was very noisy, particularly on the blue-end of the spectrum (~540-560nm), where 
luminous flux from the optical system was very low (<30% of maximum flux). The 
characteristic shape still roughly matched to the expected spectral shift curve (Fig. 5.5B), 
calculated from a simulated 5nm shift in colloidal UV-Vis spectra of nanoprisms of the 
same size. Following pixel-by-pixel calculation of change in spectral shape as described 
above, the heat map in Figure 5.5C was acquired. Large spectral shifts were obtained from 
the hybridization region (Spectral Change > 0.3), though only near the center where 
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illumination was brightest. Overall, the signal was very noisy, and artifacts were observed 
that could obscure results. In order to reduce these effects, the measured spectrum was 
reduced to 560-640nm, removing portions of the spectrum with low optical flux. The 
Hamamatsu CCD was replaced with a Reitiga EXi camera with integration functionality 
and the DMD program was modified to double the resolution across the remaining 
spectrum, down to 2nm, as the loss in optical flux would be accounted for by integration 
time. 
 
Figure 5.5. A) Average measured shift in absorbance spectrum in the region of interest following 
on-chip PCR targeting the E. coli DXS gene with an initial input of 500fg/µL DNA. While the 
spectrum demonstrates significant noise concerns, the overall shape is reminiscent of B) the 
expected shift for particles of the same size over the spectral region from 540-670nm. C) Heat map 
showing spectral shift measurements in the region of interest as a measure of spectral shape change. 
As in chapter 4, measurements above 0.15 are considered to be significant. While positive results 
were observed, significant noise and imaging artifacts were present using this analysis. 
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5.4.3 Limit of Detection Analysis 
Following these changes, the combined PCR/LSPR detection chip was tested for 
limit of detection. Prior to each experiment, the PCR chip was disassembled, treated with 
DNase, sonicated in 70% ethanol, and heated to 70C to remove any residual enzymes prior 
to being reassembled with a freshly prepared glass coverslip coated with nanoplates and 
functionalized with DNA probes. The chip was then filled with PCR solutions containing 
0, 5, 50, 500 and 5000 fg/µL of DNA isolated from Stbl3 E.coli as described above. For 
each sample, the chip was allowed to thermocycle for 35 cycles with spectral 
measurements taken every three minutes. Measurements consisted of 170 images taken 
over 40 wavelength points in the range from 560-640nm for ~2nm resolution using a 
Reitiga EXi camera with 250ms integration time. Figure 5.6A shows the average measured 
shift in spectral peak in the detection zone over the course of thermocycling for the various 
starting concentrations of DNA. In cases with higher concentrations of DNA, peak spectral 
shift was observed within 10-15 minutes, or less than 20 cycles. Signal was still observed 
at 5fg/µL, though it was significantly lower indicating that amplification occurred, but not 
to the level of higher concentration samples. These results indicated that the limit of 
detection of the system was ~5fg/µL, which corresponds to ~300 bacteria/mL of 
sample[334]. Fig. 5.6B shows the measured average spectral shift by input DNA 
concentration, indicating a plateau at an average spectral shift of ~0.5%. Interestingly, 
seemingly cyclical distortions in the spectral shift data were observed, possible indicating 
some effect on hybridization from changes in temperature or small motion artifacts. 
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Figure 5.6. A) Average spectral shift over time in the ROI as measured by percentage difference 
from the initial spectrum. Input DNA concentrations of 0, 5, 50, 500, 5000 fg/µL demonstrated. 
Dashed lines indicate best-fit regression for each experiment. B) Maximum average shift as a 
function of input DNA concentration. Plateau occurs at an average shift of ~0.4%. Note that average 
shift across the ROI accounts for both hybridized pixels and non-hybridized, maximum spectral 
shifts were measured at ~1% in these cases. Error bars indicate error from regression. 
 
 While the average spectral shift measured in the region of interest peaked at 0.5%, 
the calculated difference maps demonstrated improved signal. Measured signal shift was 
not fully consistent from one pixel to the next, indicating randomly speckled binding in the 
hybridization zone that never fully saturates. As a result, the regional average measure 
accounted for both pixels displaying strong plasmonic shift and those that weren’t. 
Maximum spectral shift observed on a pixel-by-pixel basis was consistently double the 
average measurement, or approximately 1% for DNA concentrations in the plateau region 
of the response curve. Figure 5.7 demonstrates this effect, showing time-lapsed images of 
the ROI taken with an input DNA concentration of 5fg/µL. While the regional average 
spectral shift was approximately 0.2% at this concentration, the maximum spectral shift 
reached 0.45% with many pixels at 0.3-0.35%. 
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Figure 5.7. Heat map series showing spectral shift over time in the region of interest expressed as 
a percentage of initial spectra. All data were generated using 5fg/µL input. Probes were localized 
to a round droplet in the center of the hybridization region. While the largest shifts observed were 
~0.5%, a clear increase in signal over time is observed over the course of thermocycling. Time 
points are A) initial, B) 9m, C) 15m, D) 21m, E)30m.  
 
5.4.4 On-Chip Multiplex PCR 
Following demonstration of single-target PCR, the potential for multiplex PCR 
utilizing the looped-flow thermocycler/LSPR system was evaluated. A detection zone was 
prepared as before on a glass slide, but the DNA probes were instead placed in droplets to 
define two separate regions of interest targeting different genes (tufB and DXS). As before, 
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a 10µL droplet of each probe at 35µM concentration was placed on the monolayer surface 
and allowed to incubate for one hour before washing with diH2O. A PCR chip was then 
constructed using the multiplex coverslip.  
After the multiplex chip was constructed, DNA samples were prepared by 
separately performing PCR targeting tufB and DXS genes with E.coli DNA input. The 
samples were separated using gel electrophoresis, and the bands indicating the two genes 
were cut out of the gels, melted with guanidine hydrochloride and isolated using a DNEasy 
solid-phase extraction kit (Qiagen, Hilden, Germany). PCR experiments for the multiplex 
chip were then performed by preparing PCR solutions with combinations of the two DNA 
isolates: positive for both genes, negative for both, and +/- for each. 200nM concentrations 
of both sense and antisense primers for each target were used, with 500fg/µL 
concentrations of positive input DNA to ensure complete amplification. Fig. 6 shows 
pseudocolor  difference map images for the multiplex PCR experiment. Similar maximum 
spectral shift values were observed, at approximately 1% spectral shift in hybridization 
zones for positive samples. These results demonstrate that multiplex PCR is possible using 
the looped PCR/LSPR chip.  
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Figure 5.8. Output heat map spectra for multiplex PCR experiments. In all cases, tufB 
probes localized to left side of the image and DXS probes to the right. A) Blank (no input 
DNA), B) tufB positive, DXS negative, C) tufB negative, DXS positive. Note that while 
output is noisy, clear localization of signal in the hybridization regions can be seen. 
 
5.5 DISCUSSION 
A microfluidic PCR chip utilizing piezoelectrically pumped looped flow and 
an LSPR based detection scheme was constructed and validated, demonstrating a 
limit of detection of 5fg/µL, indicating a level of resolution comparable to or better 
than most conventional PCR systems. Detection of target markers occurred 
consistently within 20 minutes, allowing for rapid diagnosis, with potential for even 
faster detection with shorter step times and improved heating rates achievable by 
replacing the TEC. Additionally, on-chip multiplex detection was demonstrated, 
increasing the diagnostic potential of such a device. The label-free nature of LSPR 
compared to standard hybridization arrays or fluorescent detection allows for the 
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possibility of large arrays with real-time analysis. The looped design of the device 
makes it ideal for addition to a continuous flow sample preparation system to isolate 
bacteria from a blood sample for rapid detection of resistance markers in patients 
suffering from BSIs. 
While consistent detection of very low signal was demonstrated, resolving 
average spectral shifts as low as 0.2%, overall plasmonic shift from the hybridization 
arrays were lower than expected, indicating a lack of binding saturation that could 
prove difficult to overcome for any potential increase in device sensitivity. 
Additionally, periodic drop-off in signal was observed during PCR detection. This 
could be due to chance overlap of camera imaging with certain heating cycles – tying 
camera control to certain steps in thermocycling much like motion control for 
CT/MR scanning could help reduce these effects. On the whole, a combined 
LSPR/PCR chip has been described that serves as an excellent detection platform 
with potential for expansion with in-flow sample preparation systems. 
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CHAPTER 6: 
Conclusions and Future Directions 
6.1 CONCLUSIONS 
 Due to the prevalence of nosocomial bloodstream infections and the associated 
mortality and costs, there is an urgent need for rapid, inexpensive assays for 
characterization of causative pathogens and antimicrobial resistances. This would allow 
for timely treatment while minimizing the risk of developing new resistant strains and 
superbugs inherent in broad spectrum antimicrobial treatment, a critical concern in modern 
medicine. Since such an assay would need to be able to detect a wide range of resistances 
and pathogenic species, genetic markers are an ideal avenue for analysis. As the 
concentration of pathogens in BSIs are often very low, amplification prior to detection 
makes PCR based assays an ideal option, particularly when coupled with microfluidics for 
rapid analysis and potential for automation and side-by-side assays. 
 The major components of a PCR-based microfluidic system are thermocycling and 
temperature control, the fluidic assembly itself, and a detection scheme. In Chapter 3, 
fluidic and thermocycling systems were developed with a focus on integration of a DNA 
hybridization array detection scheme for multiplex analysis. A rapid thermocycling 
platform was created using a thermoelectric heating element controlled by an integrated 
resistance thermal detector connected to a control board with custom software. Coupled 
with a fluidic chip utilizing an aluminum substrate for thermal conductivity, three step PCR 
was achieved with a minimal time between steps of <10s, leading to potential assay time 
of less than 20 minutes and highly stable thermal control. A continuous flow looped 
thermocycling chip allows for the potential of in-line integration into sample preparation 
systems. 
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 Multiplex detection of genetic markers following PCR requires probes specific to 
the markers amplified – simple detection of DNA quantity would not differentiate between 
signals. Chapter 4 discusses the optimization of silver nanoprisms for use in a monolayer 
LSPR imaging hybridization array and the subsequent development of a two-dimensional 
spectroscopic imaging system for LSPR applications. A highly-tunable citrate stabilized 
silver nanoprism synthesis protocol was developed for maximal stability and 
functionalizability. These were then used for an LSPR imaging system which demonstrated 
ability to detect a shift in absorption spectra as low as 0.2% of the signal. This sensor, while 
not as sensitive as classical LSPRi systems, is significantly lower cost due to usage of a 
DMD to create spectral resolution rather than full spectroscopy. In addition to the 
application utilized in this dissertation, such a system has a wide array of potential uses for 
biosensors due to the label-free and assay non-specific nature of LSPR. 
 With all three major components of a microfluidic PCR-based total analysis system 
functional, they were integrated (see Chapter 5) to create a system capable of multiplex 
detection of genetic markers from a lysed cell input. The limit of detection of the device 
was characterized, resulting in a lower limit of 5fg/µL of E.coli DNA, approximately 
equivalent to 59 bacteria, or copies of the target gene in a 200µL sample. While this 
concentration is not ideal for detection directly from a clinical blood sample due to the low 
concentration of pathogens in a typical patient with a BSI, it was still surprisingly low, and 
the continuous flow microchip system lends itself well to adaptation of a sample 
preparation system for increasing the concentration of pathogens. In addition, multiplex 
PCR analysis was successfully demonstrated, indicating the potential value for analysis of 
panels of genetic targets in a short period of time. 
 The primary focus of the studies in this dissertation was the development of a 
microfluidic total analysis system designed to take in a pathogen sample, run genetic 
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analysis and determine the presence of a targeted set of genetic antimicrobial resistance 
markers in less than two hours in order to minimize the time to effective treatment for 
patients with bloodstream infections. This work demonstrated a fully realized system 
utilizing a TEC-based thermocycler and looped continuous flow chip with an optical LSPR 
imaging system for interrogation of nanoparticle absorption shift with changes in the local 
dielectric constant due to DNA hybridization between thiol-immobilized probes and target 
genetic sequences. The hybridization array design allows for multiplex analysis alongside 
the label-free and highly sensitive detection of LSPR imaging. While the resulting limit of 
detection was not sensitive enough for direct clinical usage without some form of sample 
preparation, the overall platform design provides potential for in-line application with 
sample preparation systems to make it viable for clinical samples.  
6.2 FUTURE DIRECTIONS 
6.2.1 Optical and Microfluidic Improvements 
 There is significant opportunity for expansion on the work demonstrated in this 
dissertation. Further refinement of optical systems, particularly focused on reduction of the 
inherent diffraction effect found in digital micromirror devices, would allow for increasing 
the luminous flux of the system and thus its sensitivity. Similarly improving camera 
sensitivity could allow for a reduced integration time, and thus more measurements taken 
over time. Automation of camera control could also be used to reduce time between 
spectral measurements. 
On the microfluidics side of the system, the demonstration of multiplex PCR 
detection opens the door for hybridization panel assays, so characterizing the maximum 
number of potential targets for amplification and detection in a single multiplex experiment 
and any effects on SNR would be highly valuable. Other potential avenues of exploration 
include optimization for usage of stochastic hybridization probes for bacterial 
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characterization, implementation of alternative reagents for faster PCR protocols, and 
development of a reagent mix for optimal PCR results. 
6.2.2 Sample Preparation Systems 
Beyond the current scope of the project, the continuous flow design paradigm 
adopted for the fluidic components developed herein was intended for the primary purpose 
of being a modular component of a more extensive total analysis system or other assays. 
Notably, sample preparation prior to thermocycling would allow for isolation of pathogens 
from clinical samples and subsequent lysis to concentrate the sample input to the PCR 
system and allow for rapid detection of resistance markers directly. Such a sample 
preparation system could consist of introduction of a lysis buffer containing saponin, 
polyethylene glycol and sodium polyanetholesulfonate[111] for debulking of human blood 
cells, both red and white, followed by a system for concentration of pathogens using a 
technique such as dielectrophoretic field-flow fractionation (DEP-FFF). DEP-FFF has 
previously been demonstrated for trapping of bacteria[335], viruses[336] and fungal 
spores[337], and could thus be used to isolate such pathogens into a plug flow for input 
into the thermocycling system. 
 Of course, such an input system would require lysis as well prior to thermocycling 
– PCR requires free DNA, and cellular proteins can inhibit the activity of polymerase, thus 
preventing the reaction from occurring. Treatment of pathogens with sodium dodecyl 
sulfate has been shown to result in efficient lysis through solubilization of cell walls and 
viral capsids. While SDS is also known to inhibit PCR by denaturing DNA polymerase 
enzymes, inclusion of 0.5% Tween-20 in the reaction buffer neutralizes SDS and prevents 
this, thus allowing for potential PCR following SDS-mediated lysis[163]. 
 Further potential sample preparation side advancements include DNA isolation to 
improve the limit of detection by concentrating DNA into a smaller sample volume while 
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simultaneously removing potential protein contaminants. Possible approaches for DNA 
isolation from bulk solution include solid phase extraction electrophoretic focusing 
methods. Solid phase extraction techniques for DNA isolation utilize a silicon-based sol 
gel which DNA will bind to in the presence of a salt such as guanidine hydrochloride. 
Following binding, trapped DNA is released in the presence of polar solvents. While 
effective and commonly used in microbiology laboratories for isolation and purification of 
DNA, solid phase extraction requires flow through a column, multiple buffer washes, and 
chemical agents that inhibit PCR. On-chip solid phase extraction has been demonstrated, 
but it is not ideal for a continuous flow system[338]. 
6.2.3 Electrophoretic DNA Focusing 
 Electrophoretic isolation is much more ideal for continuous flow applications, and 
lends itself well to use in a series of sample preparation components prior to analysis. In 
principle, an electric field is applied transverse to a fluidic channel to induce 
electrophoretic motion in charged molecules such as DNA to isolate them into a flow 
stream for output. The primary drawback of electrophoresis across a channel structure is 
the formation of microbubbles due to electrolysis of water at the surface of the electrodes, 
which could subsequently be disastrous for PCR. In order to avoid this, a channel structure 
with sidewalls composed of 3.5kD dialysis membrane can be used, placing electrodes 
outside the channel structure in buffer reservoirs. This allows small ions to pass the 
membrane and maintain an electric field while larger DNA molecules remain inside the 
channel and microbubbles form exclusively external (Fig 6.1). In this manner, an H-bridge 
channel layout can be used to transfer DNA to a second sample stream. 
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Figure 6.1. A) Diagram of transverse electrophoretic concentrator for DNA inputs. The system 
uses an H-bridge design in conjunction with dialysis membrane separating the sample channel from 
electrodes in buffer solution to prevent formation of microbubbles through electrolysis. B) Gel 
electrophoresis of bulk DNA with and without intervening dialysis membrane. DNA in the path of 
the membrane did not pass through, indicating that the pore size was small enough to keep DNA 
in the channel. C) Electrophoretic focusing of negatively charged fluorescent beads from an input 
stream (left) into the secondary output stream (right). D) Electrophoretic focusing of DNA from a 
single input (left) into the output stream (right). 
 
 In preliminary experiments performed for this potential technique, multiple channel 
cross-sections were utilized for transverse electrophoretic focusing (Fig. 6.2A). DNA 
concentration was successfully increased from a single bulk solution input into a reduced 
output stream, however DNA trapping against the dialysis membrane where the net flow 
rate was zero due to boundary conditions prevented recovery of significant portions of 
DNA input to the system. In a diagnostic system that requires all present DNA to accurately 
assess the range of markers present in the sample, this is an unacceptable trade-off. 
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Figure 6.2. A) Design iterations on electrophoretic DNA concentrator. From left to right, PDMS 
H-bridge, narrowed PMMA H-bridge, Y-bridge for concentrating from a single source flow, 
widening Y-bridge to reduce DNA trapping at the membrane interface from boundary flow 
conditions. B) DNA concentration as a percentage of input as measured from both concentrator and 
waste output flows. Maximum focusing was found to occur at 10V/cm, stronger electric fields 
resulted in turbulent flow and increased trapping, as seen in C), total DNA recovery from both 
outputs following focusing. Electric fields above 10V/cm resulted in decreased recovery of DNA 
due to higher levels of trapping at membranes. 
 
 While DNA trapping against the channel wall prevents transverse electrophoretic 
concentration from viability in a system such as the one presented herein, the same physical 
concepts can be applied to the concept of isoelectric focusing[339]. An ampholytic buffer 
solution can be introduced to the microchip by sheath flow on either side of the primary 
input. This creates a spatially resolved pH gradient across the channel which can then be 
used to separate biomolecules by isoelectric point – the pH at which the net charge of the 
molecule becomes zero, thus leading to zero electrophoretic mobility. DNA carries a 
characteristic isoelectric point of 4-4.2, so output flow can be set using relative flow rates 
to isolate this pH band. 
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Figure 6.3. Schematic of a potential isoelectric focusing flow chamber. Sheath flow is induced 
from two pH buffers, creating a pH gradient across the channel. Organic molecules, including 
DNA, will localize to the electrophoretic force minimum, the point at which their charge is zero, 
or isoelectric point. An output tuned to collect this pH band in the gradient can then be used to 
isolate DNA away from other biomolecules and debris. 
 
6.2.4 Parallel Assays 
 One of the greatest advantages of utilizing both a microfluidic system and a label-
free detection method such as LSPR imaging is that there is strong potential for parallel 
assays within the same chip design paradigm and sensing method. LSPR imaging has been 
demonstrated for detection of analytes in a wide variety of commonly used molecular 
biology assays, including ELISA[340], cell assays[341], and others. With a sample 
preparation step to separate sample streams and careful tuning of flow chamber resistances, 
it would be possible to expand the device presented here to perform more than one of these 
assays simultaneously. For example, proteins separated during a DNA isolation step could 
be diverted to a channel passing over an LSPR imaging array functionalized with 
antibodies for protein targets, allowing simultaneous analysis of pathogenic DNA and 
protein content with minimal increase in device costs. While addition of other detection 
modalities would allow for even further exploration, multiple detection schemes would 
dramatically increase the cost of manufacturing and maintenance. 
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APPENDIX 
Appendix A - Circuit Diagram for TEC Thermocycler 
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Appendix B - PID Control Program for Arduino – AmpliTaq Gold PCR Protocol 
// PCR Thermocycle control through RTD 
 
// Initialize all global variables for the program 
int cycle = 1; 
int maxCycle = 36; 
int currentStep = 0; 
int pulseMax = 100; 
int timeStep = 100; //Time step in milliseconds 
double integral = 0; //PID control variables 
double diff = 0; 
double previousError = 0; 
int timeAtTemp = 0; //Time since current target reached 
int ct = 0; 
boolean firstPoint = true; 
double sets[] = {96, 64, 70}; //Target temperatures 
int locks[] = {75, 10, 30}; //"Lock" points for each target (output at which the temperature is stable) 
double set = 95; 
int lock = 75; 
int pulseSum = 0; 
boolean atTarget = false; 
boolean problem = false; //True if an error is encountered, resets current step 
int repeatErrorCount = 0; //Check for repeated incorrect error readings 
 
void setup(){ 
  // Initialize feed to computer 
  Serial.begin(9600); 
  Serial.println("Vin    Temperature    Error    Integral   Pulse Time    Target Time   Cycle"); 
   
  // Set output pins to H-bridge 
  pinMode(2, OUTPUT); 
  pinMode(3,OUTPUT); 
  digitalWrite(0,LOW); 
  digitalWrite(0,LOW); 
} 
 
// Main program loop 
void loop(){ 
  // Exit functionality if the program is done or a problem is encountered (the loop never ends on Arduino, 
  // so the controller will just idle) 
  if (cycle<=maxCycle && !problem){ 
     
    boolean stepChange = false; 
    // Check for end of step conditions, modify targets appropriately\ 
    //55 
    if (currentStep == 2 && timeAtTemp > 0 && set > 60){ 
      set = set - 0.08; 
    } 
    if (timeAtTemp == 65 && currentStep == 2){ 
      currentStep = 3; 
      set = sets[2]; 
      lock = locks[2]; 
      locks[1] = pulseSum/(timeAtTemp - 10); 
      stepChange = true; 
    } 
    //55 
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    if (timeAtTemp == 55 && currentStep == 1){ 
      currentStep = 2; 
      set = sets[1]; 
      lock = locks[1]; 
      if (cycle != 1){ 
        locks[0] = pulseSum/(timeAtTemp - 10); 
      } 
      stepChange = true; 
    } 
    //100 
    if (timeAtTemp == 100 && currentStep == 3){ 
      if (cycle!= 35){ 
        currentStep = 1; 
        set = sets[0]; 
        lock = locks[0]; 
        locks[2] = (locks[2] + pulseSum/(timeAtTemp - 10))/2; 
        stepChange = true; 
      } else{ 
        timeAtTemp = 0; 
      } 
      cycle++; 
    } 
     
    // First step, first cycle ending 
    if (timeAtTemp == 2400 && cycle == 1 && currentStep == 0){ 
      currentStep = 1; 
      set = sets[0]; 
      lock = locks[0]; 
      stepChange = true; 
    } 
 
    if (stepChange){ 
      pulseSum = 0; 
      integral = 0; 
      pulseMax = 100; 
      timeAtTemp = 0; 
      firstPoint = true; 
      atTarget = false; 
      stepChange = false; 
    } 
     
    // Read in voltage and calculate current temperature 
    double input = analogRead(0); 
    double vin = 5*input/1024; 
    double res = (1280*(vin + 21.55))/(28.05 - vin); 
    double temp2 = (res - 1000)/3.853; 
    double temp = 25 + 1.2*(temp2-25); 
     
    // Calculate error 
    double error = set - temp; 
     
    // If the error is more than 3 degrees above the target, something is wrong - cease heating 
    if (error < -2 && (currentStep!=2 || atTarget)){ 
      problem = true; 
    } 
     
    // Within two degrees of target, start count and activate the integral 
    // Original second condition: ((currentStep!=2 && error < 2) || (currentStep==2 && abs(error) < 1)) 
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    if (!atTarget && ((currentStep!=2 && error < 2) || (currentStep==2 && error >= -1 && temp > 0))){ 
      atTarget = true; 
      integral = (pulseMax*lock)/200; 
    } 
     
    if (!firstPoint){ 
      // If the change in error is too high, there is a misread, keep the old error 
      if (abs(error - previousError) > 7){ 
        error = previousError; 
        repeatErrorCount++; 
        // If too many high change errors encountered in a row, heating is out of control and needs to be stopped 
        if (repeatErrorCount > 5){ 
          problem = true; 
        } 
      } else {repeatErrorCount = 0;} 
      diff = 10*(error - previousError); // Calculate differential term 
    } 
     
    // If the target is near, calculate the integral term and increment target count 
    if (atTarget){ 
      integral += (error/4); 
      timeAtTemp++; 
    } 
     
    previousError = error; 
    int PIDout = error + 2*diff + 2*integral; // Calculate PID output 
     
    if (abs(error) < 5){ 
      PIDout = 2*error + 2*diff + 2*integral; 
    } 
     
    // If PID output is greater than the max seen thus far, update the max 
    if (abs(PIDout) > pulseMax){ 
      pulseMax = abs(PIDout); 
    } 
    int pulseOut = (timeStep*PIDout)/pulseMax; // Calculate pulse output time (milliseconds) 
     
    // If not at the target yet, full power 
    if (!atTarget){ 
      if (currentStep==3){ 
        pulseOut = timeStep - 10; 
         
        // If getting close to target, reduce power towards lockpoint to prevent overshoot 
        if (error < 10){ 
          pulseOut = lock + (timeStep - lock)*error/10; 
          if (ct%10==0 && error < 5){ 
            lock = lock + 1; 
          } 
        } 
      }else if(currentStep!=2){ 
         pulseOut = timeStep; 
      }else{ pulseOut = -1*(timeStep-15);} //Until problem with Peltier cooling is fixed 
    } 
     
    if (temp<0 || temp > 97 || problem){ pulseOut = 0;} 
    // Output in the appropriate direction to h-bridge 
    if (pulseOut > 0){ 
      digitalWrite(3,LOW); 
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      digitalWrite(2,HIGH); 
      delay(pulseOut); 
    } else if (pulseOut < 0){ 
      digitalWrite(2,LOW); 
      digitalWrite(3,HIGH); 
      delay(abs(pulseOut)); 
    } 
    // If not running at full power, turn off output for appropriate time 
    if (abs(pulseOut) < timeStep){ 
      int downPulse = timeStep - abs(pulseOut); 
      digitalWrite(2,LOW); 
      digitalWrite(3,LOW); 
      delay(downPulse); 
    } 
     
    if (timeAtTemp > 10 && cycle != 1){ 
      pulseSum += pulseOut; 
    } 
     
    // Output relevant stats to computer screen once per second 
    if (ct%10 == 0){ 
      if (ct != 0 && ct%200 == 0){ 
        Serial.println(); 
        Serial.println("Vin    Temperature    Error    Integral   Pulse Time    Target Time   Cycle"); 
      } 
       
      Serial.print(vin); 
      Serial.print("      "); 
      Serial.print(temp); 
      Serial.print("       "); 
      Serial.print(error); 
      Serial.print("      "); 
      Serial.print(integral); 
      Serial.print("         "); 
      Serial.print(pulseOut); 
      Serial.print("           "); 
      Serial.print(timeAtTemp/10); 
      Serial.print("         "); 
      Serial.println(cycle); 
    } 
    ct++; 
    firstPoint = false; 
  } else{ 
   
    // If outside the main program, shut down output. The controller will idle here after program completion. 
    digitalWrite(2,LOW); 
    digitalWrite(3,LOW); 
     
    // If the program was exited because of an error, reset the target count and reactivate 
    if (problem){ 
      atTarget = false; 
      firstPoint = true; 
      problem = false; 
    } 
  } 
} 
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